cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
LIHC	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-23.58	2.22e-73	-0.91	-0.79	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-23.58	2.22e-73	-0.91	-0.79	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	23.57	2.45e-73	0.92	0.79	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	23.57	2.45e-73	0.92	0.79	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	23.05	2.66e-71	0.91	0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	23.05	2.66e-71	0.91	0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-22.26	3.14e-68	-0.9	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-22.26	3.14e-68	-0.9	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-20.35	1.19e-60	-0.93	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-20.35	1.19e-60	-0.93	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-20.35	1.19e-60	-0.93	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-20.35	1.19e-60	-0.93	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-19.92	5.88e-59	-0.92	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-19.92	5.88e-59	-0.92	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-18.81	1.66e-54	-0.89	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-18.81	1.66e-54	-0.89	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-17.49	2.98e-49	-0.86	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-17.49	2.98e-49	-0.86	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
LIHC	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-14.08	9.67e-36	-0.83	-0.61	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-14.08	9.67e-36	-0.83	-0.61	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-13.93	3.58e-35	-0.84	-0.6	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	13.41	3.63e-33	0.79	0.59	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-13.25	1.51e-32	-0.8	-0.58	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-11.79	4.31e-27	-0.7	-0.54	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-11.4	1.07e-25	-0.67	-0.53	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.536	rs7306751	MIMAT0003287	hsa-miR-618	-11.06	1.76e-24	-0.7	-0.52	Dental caries;	chr12:80922459	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.536	rs4261347	MIMAT0003287	hsa-miR-618	-11.04	2.03e-24	-0.7	-0.51	Dental caries;	chr12:80921546	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.559	rs17007693	MIMAT0003287	hsa-miR-618	-10.52	1.37e-22	-0.82	-0.5	Dental caries;	chr12:80925305	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.559	rs17007699	MIMAT0003287	hsa-miR-618	-10.52	1.37e-22	-0.82	-0.5	Dental caries;	chr12:80930007	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.559	rs12228291	MIMAT0003287	hsa-miR-618	-10.1	4.06e-21	-0.79	-0.48	Dental caries;	chr12:80918034	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.559	rs7136415	MIMAT0003287	hsa-miR-618	-9.87	2.26e-20	-0.77	-0.47	Dental caries;	chr12:80915511	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	9.85	2.73e-20	0.77	0.47	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-9.85	2.81e-20	-0.61	-0.47	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.572	rs1402348	MIMAT0003287	hsa-miR-618	-9.8	4.12e-20	-0.61	-0.47	Dental caries;	chr12:80919695	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.572	rs7134827	MIMAT0003287	hsa-miR-618	-9.77	5.04e-20	-0.6	-0.47	Dental caries;	chr12:80922229	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.572	rs7303026	MIMAT0003287	hsa-miR-618	-9.77	5.25e-20	-0.6	-0.47	Dental caries;	chr12:80921967	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.572	rs7134652	MIMAT0003287	hsa-miR-618	-9.77	5.25e-20	-0.6	-0.47	Dental caries;	chr12:80922054	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.605	rs7487519	MIMAT0003287	hsa-miR-618	-9.76	5.4e-20	-0.6	-0.47	Dental caries;	chr12:80921469	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.572	rs1402349	MIMAT0003287	hsa-miR-618	-9.71	8.17e-20	-0.6	-0.47	Dental caries;	chr12:80919985	chr12:80935796~80935818:-
LIHC	cis	rs2277912	0.865	rs111954117	MIMAT0014995	hsa-miR-3130-5p	9.53	3.2e-19	0.61	0.46	Height;	chr2:206793017	chr2:206783276~206783296:-
LIHC	cis	rs2277912	0.865	rs111954117	MIMAT0014995_1	hsa-miR-3130-5p	9.53	3.2e-19	0.61	0.46	Height;	chr2:206793017	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-8	2.03e-14	-0.6	-0.4	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-8	2.03e-14	-0.6	-0.4	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
LIHC	cis	rs1163656	0.819	rs1795515	MIMAT0003287	hsa-miR-618	7.64	2.27e-13	0.52	0.38	Dental caries;	chr12:80941888	chr12:80935796~80935818:-
LIHC	cis	rs1163656	0.819	rs1716537	MIMAT0003287	hsa-miR-618	7.64	2.32e-13	0.52	0.38	Dental caries;	chr12:80940959	chr12:80935796~80935818:-
LIHC	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-7.6	2.86e-13	-0.57	-0.38	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-7.6	2.86e-13	-0.57	-0.38	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
LIHC	cis	rs1163656	0.559	rs1163657	MIMAT0003287	hsa-miR-618	7.59	3.16e-13	0.58	0.38	Dental caries;	chr12:80943890	chr12:80935796~80935818:-
LIHC	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-7.39	1.14e-12	-0.57	-0.37	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-7.39	1.14e-12	-0.57	-0.37	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
LIHC	cis	rs1163656	0.592	rs1795514	MIMAT0003287	hsa-miR-618	7.35	1.52e-12	0.56	0.37	Dental caries;	chr12:80939088	chr12:80935796~80935818:-
LIHC	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-7.31	1.91e-12	-0.45	-0.37	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-7.18	4.51e-12	-0.44	-0.36	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-7.14	5.72e-12	-0.44	-0.36	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
LIHC	cis	rs1163656	0.605	rs10778771	MIMAT0003287	hsa-miR-618	-7.08	8.49e-12	-0.49	-0.36	Dental caries;	chr12:80924235	chr12:80935796~80935818:-
LIHC	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-6.97	1.68e-11	-0.38	-0.35	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-6.97	1.68e-11	-0.38	-0.35	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	6.96	1.8e-11	0.38	0.35	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-6.94	2.04e-11	-0.43	-0.35	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-6.92	2.26e-11	-0.38	-0.35	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-6.92	2.26e-11	-0.38	-0.35	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-6.9	2.5e-11	-0.38	-0.35	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-6.9	2.65e-11	-0.37	-0.35	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-6.87	3.14e-11	-0.37	-0.35	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-6.85	3.57e-11	-0.37	-0.35	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-6.81	4.55e-11	-0.37	-0.35	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-6.78	5.42e-11	-0.37	-0.35	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-6.78	5.42e-11	-0.37	-0.35	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-6.76	5.98e-11	-0.36	-0.35	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-6.76	5.98e-11	-0.36	-0.35	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-6.76	5.98e-11	-0.36	-0.35	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-6.76	5.98e-11	-0.36	-0.35	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-6.76	6.21e-11	-0.37	-0.34	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-6.76	6.21e-11	-0.37	-0.34	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-6.76	6.22e-11	-0.37	-0.34	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-6.76	6.22e-11	-0.37	-0.34	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-6.76	6.22e-11	-0.37	-0.34	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
LIHC	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-6.76	6.22e-11	-0.37	-0.34	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-6.76	6.22e-11	-0.37	-0.34	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-6.68	9.63e-11	-0.37	-0.34	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-6.68	9.63e-11	-0.37	-0.34	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-6.68	9.63e-11	-0.37	-0.34	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-6.68	9.63e-11	-0.37	-0.34	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-6.68	9.63e-11	-0.37	-0.34	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-6.62	1.41e-10	-0.37	-0.34	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-6.62	1.41e-10	-0.37	-0.34	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-6.62	1.41e-10	-0.37	-0.34	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-6.57	1.91e-10	-0.36	-0.34	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-6.57	1.91e-10	-0.36	-0.34	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-6.57	1.93e-10	-0.36	-0.34	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-6.57	1.93e-10	-0.36	-0.34	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-6.57	1.93e-10	-0.36	-0.34	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-6.57	1.93e-10	-0.36	-0.34	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
LIHC	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-6.57	1.93e-10	-0.36	-0.34	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
LIHC	cis	rs2277912	1	rs3762567	MIMAT0014995	hsa-miR-3130-5p	6.53	2.38e-10	0.5	0.33	Height;	chr2:206765614	chr2:206783276~206783296:-
LIHC	cis	rs2277912	1	rs3762567	MIMAT0014995_1	hsa-miR-3130-5p	6.53	2.38e-10	0.5	0.33	Height;	chr2:206765614	chr2:206783246~206783266:+
LIHC	cis	rs2277912	1	rs2277912	MIMAT0014995	hsa-miR-3130-5p	6.53	2.4e-10	0.49	0.33	Height;	chr2:206769512	chr2:206783276~206783296:-
LIHC	cis	rs2277912	1	rs2277912	MIMAT0014995_1	hsa-miR-3130-5p	6.53	2.4e-10	0.49	0.33	Height;	chr2:206769512	chr2:206783246~206783266:+
LIHC	cis	rs6543140	0.964	rs6543144	MIMAT0019927	hsa-miR-4772-3p	-6.51	2.7e-10	-0.36	-0.33	Blood protein levels;	chr2:102476116	chr2:102432336~102432357:+
LIHC	cis	rs2277912	1	rs12620432	MIMAT0014995	hsa-miR-3130-5p	6.47	3.36e-10	0.49	0.33	Height;	chr2:206771794	chr2:206783276~206783296:-
LIHC	cis	rs2277912	1	rs12620432	MIMAT0014995_1	hsa-miR-3130-5p	6.47	3.36e-10	0.49	0.33	Height;	chr2:206771794	chr2:206783246~206783266:+
LIHC	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-6.47	3.37e-10	-0.35	-0.33	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
LIHC	cis	rs2277912	1	rs56243714	MIMAT0014995	hsa-miR-3130-5p	6.35	6.88e-10	0.48	0.33	Height;	chr2:206776345	chr2:206783276~206783296:-
LIHC	cis	rs2277912	1	rs56243714	MIMAT0014995_1	hsa-miR-3130-5p	6.35	6.88e-10	0.48	0.33	Height;	chr2:206776345	chr2:206783246~206783266:+
LIHC	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	6.33	7.84e-10	0.46	0.33	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
LIHC	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	6.31	8.84e-10	0.47	0.32	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
LIHC	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	6.3	9.1e-10	0.46	0.32	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
LIHC	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	6.3	9.1e-10	0.46	0.32	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
LIHC	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	6.3	9.1e-10	0.46	0.32	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
LIHC	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	6.23	1.41e-09	0.45	0.32	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
LIHC	cis	rs2277912	1	rs17214385	MIMAT0014995	hsa-miR-3130-5p	6.22	1.5e-09	0.49	0.32	Height;	chr2:206816879	chr2:206783276~206783296:-
LIHC	cis	rs2277912	1	rs17214385	MIMAT0014995_1	hsa-miR-3130-5p	6.22	1.5e-09	0.49	0.32	Height;	chr2:206816879	chr2:206783246~206783266:+
LIHC	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	6.21	1.57e-09	0.45	0.32	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
LIHC	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	6.21	1.57e-09	0.45	0.32	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
LIHC	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	6.21	1.57e-09	0.45	0.32	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
LIHC	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-6.18	1.86e-09	-0.35	-0.32	Migraine;	chr10:103415374	chr10:103394341~103394361:-
LIHC	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	6.09	3.03e-09	0.44	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	6.09	3.03e-09	0.44	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
LIHC	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-6.06	3.64e-09	-0.36	-0.31	Migraine;	chr10:103286250	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-6.06	3.64e-09	-0.36	-0.31	Migraine;	chr10:103286932	chr10:103394341~103394361:-
LIHC	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	6.05	3.77e-09	0.45	0.31	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
LIHC	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	5.99	5.43e-09	0.35	0.31	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-5.98	5.72e-09	-0.35	-0.31	Migraine;	chr10:103365694	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-5.98	5.72e-09	-0.35	-0.31	Migraine;	chr10:103369141	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-5.97	6.09e-09	-0.35	-0.31	Migraine;	chr10:103315955	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	5.96	6.2e-09	0.34	0.31	Migraine;	chr10:103263177	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-5.95	6.63e-09	-0.35	-0.31	Migraine;	chr10:103295206	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-5.95	6.63e-09	-0.35	-0.31	Migraine;	chr10:103296155	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-5.95	6.77e-09	-0.35	-0.31	Migraine;	chr10:103394332	chr10:103394341~103394361:-
LIHC	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	5.94	7.05e-09	0.45	0.31	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
LIHC	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-5.92	7.82e-09	-0.34	-0.31	Migraine;	chr10:103254113	chr10:103394341~103394361:-
LIHC	cis	rs7255436	0.965	rs4044435	MIMAT0021017	hsa-miR-4999-5p	5.91	8.16e-09	0.43	0.31	HDL cholesterol;	chr19:8383293	chr19:8389340~8389360:-
LIHC	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	5.9	8.93e-09	0.34	0.31	Migraine;	chr10:103236031	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-5.84	1.24e-08	-0.35	-0.3	Migraine;	chr10:103338267	chr10:103394341~103394361:-
LIHC	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	5.75	2e-08	0.31	0.3	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
LIHC	cis	rs2277912	1	rs72957112	MIMAT0014995	hsa-miR-3130-5p	5.7	2.64e-08	0.45	0.3	Height;	chr2:206830729	chr2:206783276~206783296:-
LIHC	cis	rs2277912	1	rs72957112	MIMAT0014995_1	hsa-miR-3130-5p	5.7	2.64e-08	0.45	0.3	Height;	chr2:206830729	chr2:206783246~206783266:+
LIHC	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-5.7	2.64e-08	-0.52	-0.3	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
LIHC	cis	rs75358501	0.636	rs10932164	MIMAT0014994	hsa-miR-3130-3p	5.58	4.81e-08	0.4	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783245~206783265:-
LIHC	cis	rs75358501	0.636	rs10932164	MIMAT0014994_1	hsa-miR-3130-3p	5.58	4.81e-08	0.4	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783277~206783297:+
LIHC	cis	rs75358501	0.636	rs7580138	MIMAT0014994	hsa-miR-3130-3p	5.5	7.38e-08	0.39	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783245~206783265:-
LIHC	cis	rs75358501	0.636	rs7580138	MIMAT0014994_1	hsa-miR-3130-3p	5.5	7.38e-08	0.39	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783277~206783297:+
LIHC	cis	rs6543140	0.693	rs7579737	MIMAT0019927	hsa-miR-4772-3p	-5.45	9.5e-08	-0.3	-0.28	Blood protein levels;	chr2:102370901	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-5.4	1.27e-07	-0.23	-0.28	Migraine;	chr10:103415374	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-5.37	1.45e-07	-0.3	-0.28	Migraine;	chr10:103297804	chr10:103394341~103394361:-
LIHC	cis	rs75358501	0.584	rs11894165	MIMAT0014994	hsa-miR-3130-3p	5.3	2.06e-07	0.38	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783245~206783265:-
LIHC	cis	rs75358501	0.584	rs11894165	MIMAT0014994_1	hsa-miR-3130-3p	5.3	2.06e-07	0.38	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783277~206783297:+
LIHC	cis	rs75358501	0.688	rs1862087	MIMAT0014994	hsa-miR-3130-3p	5.3	2.06e-07	0.38	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783245~206783265:-
LIHC	cis	rs75358501	0.688	rs1862087	MIMAT0014994_1	hsa-miR-3130-3p	5.3	2.06e-07	0.38	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783277~206783297:+
LIHC	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-5.3	2.08e-07	-0.24	-0.28	Migraine;	chr10:103295206	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-5.3	2.08e-07	-0.24	-0.28	Migraine;	chr10:103296155	chr10:103394301~103394322:-
LIHC	cis	rs17639215	0.55	rs9679297	MIMAT0019927	hsa-miR-4772-3p	-5.28	2.32e-07	-0.33	-0.28	Serum protein levels (sST2);	chr2:102298109	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-5.25	2.76e-07	-0.24	-0.27	Migraine;	chr10:103286250	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-5.25	2.76e-07	-0.24	-0.27	Migraine;	chr10:103286932	chr10:103394301~103394322:-
LIHC	cis	rs75358501	0.636	rs1862089	MIMAT0014994	hsa-miR-3130-3p	5.22	3.07e-07	0.38	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783245~206783265:-
LIHC	cis	rs75358501	0.636	rs1862089	MIMAT0014994_1	hsa-miR-3130-3p	5.22	3.07e-07	0.38	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783277~206783297:+
LIHC	cis	rs75358501	0.688	rs2287629	MIMAT0014994	hsa-miR-3130-3p	-5.22	3.16e-07	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783245~206783265:-
LIHC	cis	rs75358501	0.688	rs2287629	MIMAT0014994_1	hsa-miR-3130-3p	-5.22	3.16e-07	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783277~206783297:+
LIHC	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-5.21	3.33e-07	-0.23	-0.27	Migraine;	chr10:103365694	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-5.21	3.33e-07	-0.23	-0.27	Migraine;	chr10:103369141	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-5.16	4.21e-07	-0.23	-0.27	Migraine;	chr10:103315955	chr10:103394301~103394322:-
LIHC	cis	rs75358501	0.636	rs888621	MIMAT0014994	hsa-miR-3130-3p	-5.16	4.27e-07	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783245~206783265:-
LIHC	cis	rs75358501	0.636	rs888621	MIMAT0014994_1	hsa-miR-3130-3p	-5.16	4.27e-07	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783277~206783297:+
LIHC	cis	rs75358501	0.636	rs2241347	MIMAT0014994	hsa-miR-3130-3p	5.15	4.34e-07	0.34	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783245~206783265:-
LIHC	cis	rs75358501	0.636	rs2241347	MIMAT0014994_1	hsa-miR-3130-3p	5.15	4.34e-07	0.34	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783277~206783297:+
LIHC	cis	rs2277912	0.568	rs10490748	MIMAT0014995	hsa-miR-3130-5p	5.15	4.54e-07	0.43	0.27	Height;	chr2:206708331	chr2:206783276~206783296:-
LIHC	cis	rs2277912	0.568	rs10490748	MIMAT0014995_1	hsa-miR-3130-5p	5.15	4.54e-07	0.43	0.27	Height;	chr2:206708331	chr2:206783246~206783266:+
LIHC	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-5.14	4.73e-07	-0.23	-0.27	Migraine;	chr10:103394332	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-5.13	4.79e-07	-0.23	-0.27	Migraine;	chr10:103338267	chr10:103394301~103394322:-
LIHC	cis	rs2871473	1	rs1030024	MIMAT0019926	hsa-miR-4772-5p	5.13	4.88e-07	0.39	0.27	Blood protein levels;	chr2:102489310	chr2:102432300~102432321:+
LIHC	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-5.11	5.27e-07	-0.28	-0.27	Migraine;	chr10:103284400	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-5.11	5.46e-07	-0.21	-0.27	Migraine;	chr10:103297804	chr10:103394301~103394322:-
LIHC	cis	rs2871473	0.951	rs1030025	MIMAT0019926	hsa-miR-4772-5p	-5.06	6.96e-07	-0.39	-0.27	Blood protein levels;	chr2:102489152	chr2:102432300~102432321:+
LIHC	cis	rs2871473	1	rs2871473	MIMAT0019926	hsa-miR-4772-5p	-5.06	6.96e-07	-0.39	-0.27	Blood protein levels;	chr2:102490821	chr2:102432300~102432321:+
LIHC	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	5.04	7.59e-07	0.22	0.26	Migraine;	chr10:103236031	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-5.04	7.73e-07	-0.21	-0.26	Migraine;	chr10:103384531	chr10:103394301~103394322:-
LIHC	cis	rs59372292	0.597	rs2081197	MIMAT0021017	hsa-miR-4999-5p	5.01	8.86e-07	0.35	0.26	Coronary artery disease;	chr19:8448452	chr19:8389340~8389360:-
LIHC	cis	rs59372292	0.597	rs11666117	MIMAT0021017	hsa-miR-4999-5p	5.01	8.86e-07	0.35	0.26	Coronary artery disease;	chr19:8449010	chr19:8389340~8389360:-
LIHC	cis	rs59372292	0.619	rs11259983	MIMAT0021017	hsa-miR-4999-5p	5.01	8.86e-07	0.35	0.26	Coronary artery disease;	chr19:8450491	chr19:8389340~8389360:-
LIHC	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-5	9.31e-07	-0.28	-0.26	Migraine;	chr10:103317367	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-5	9.31e-07	-0.28	-0.26	Migraine;	chr10:103319682	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-4.99	9.63e-07	-0.21	-0.26	Migraine;	chr10:103299551	chr10:103394301~103394322:-
LIHC	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-4.99	9.76e-07	-0.28	-0.26	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
LIHC	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-4.98	1.03e-06	-0.28	-0.26	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
LIHC	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-4.96	1.11e-06	-0.21	-0.26	Migraine;	chr10:103317367	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-4.96	1.11e-06	-0.21	-0.26	Migraine;	chr10:103319682	chr10:103394301~103394322:-
LIHC	cis	rs2277912	0.568	rs10490749	MIMAT0014995	hsa-miR-3130-5p	4.96	1.11e-06	0.39	0.26	Height;	chr2:206710220	chr2:206783276~206783296:-
LIHC	cis	rs2277912	0.568	rs10490749	MIMAT0014995_1	hsa-miR-3130-5p	4.96	1.11e-06	0.39	0.26	Height;	chr2:206710220	chr2:206783246~206783266:+
LIHC	cis	rs10862219	0.701	rs6539538	MIMAT0003287	hsa-miR-618	4.95	1.15e-06	0.31	0.26	Neuroticism;	chr12:80985857	chr12:80935796~80935818:-
LIHC	cis	rs10862219	0.762	rs1402345	MIMAT0003287	hsa-miR-618	4.95	1.15e-06	0.31	0.26	Neuroticism;	chr12:80986317	chr12:80935796~80935818:-
LIHC	cis	rs10862219	0.762	rs3908181	MIMAT0003287	hsa-miR-618	4.95	1.15e-06	0.31	0.26	Neuroticism;	chr12:80987888	chr12:80935796~80935818:-
LIHC	cis	rs10862219	0.762	rs7961694	MIMAT0003287	hsa-miR-618	4.95	1.15e-06	0.31	0.26	Neuroticism;	chr12:80989724	chr12:80935796~80935818:-
LIHC	cis	rs10862219	0.701	rs12316222	MIMAT0003287	hsa-miR-618	4.95	1.15e-06	0.31	0.26	Neuroticism;	chr12:80991936	chr12:80935796~80935818:-
LIHC	cis	rs10862219	0.762	rs6539539	MIMAT0003287	hsa-miR-618	4.95	1.15e-06	0.31	0.26	Neuroticism;	chr12:80993574	chr12:80935796~80935818:-
LIHC	cis	rs10862219	0.762	rs6539540	MIMAT0003287	hsa-miR-618	4.95	1.15e-06	0.31	0.26	Neuroticism;	chr12:80993577	chr12:80935796~80935818:-
LIHC	cis	rs10862219	0.731	rs12312910	MIMAT0003287	hsa-miR-618	4.95	1.15e-06	0.31	0.26	Neuroticism;	chr12:80994324	chr12:80935796~80935818:-
LIHC	cis	rs10862219	0.721	rs12423916	MIMAT0003287	hsa-miR-618	4.95	1.15e-06	0.31	0.26	Neuroticism;	chr12:80995005	chr12:80935796~80935818:-
LIHC	cis	rs59372292	0.597	rs17160495	MIMAT0021017	hsa-miR-4999-5p	-4.95	1.17e-06	-0.34	-0.26	Coronary artery disease;	chr19:8451394	chr19:8389340~8389360:-
LIHC	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-4.94	1.23e-06	-0.21	-0.26	Migraine;	chr10:103386935	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-4.93	1.28e-06	-0.28	-0.26	Migraine;	chr10:103299551	chr10:103394341~103394361:-
LIHC	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	4.93	1.29e-06	0.21	0.26	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-4.93	1.3e-06	-0.21	-0.26	Migraine;	chr10:103395309	chr10:103394301~103394322:-
LIHC	cis	rs59372292	0.597	rs11259985	MIMAT0021017	hsa-miR-4999-5p	4.92	1.34e-06	0.34	0.26	Coronary artery disease;	chr19:8451793	chr19:8389340~8389360:-
LIHC	cis	rs75358501	0.636	rs3815686	MIMAT0014994	hsa-miR-3130-3p	4.91	1.44e-06	0.33	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783245~206783265:-
LIHC	cis	rs75358501	0.636	rs3815686	MIMAT0014994_1	hsa-miR-3130-3p	4.91	1.44e-06	0.33	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783277~206783297:+
LIHC	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-4.91	1.45e-06	-0.28	-0.26	Migraine;	chr10:103309363	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-4.9	1.46e-06	-0.21	-0.26	Migraine;	chr10:103358705	chr10:103394301~103394322:-
LIHC	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-4.89	1.54e-06	-0.28	-0.26	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
LIHC	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-4.88	1.6e-06	-0.2	-0.26	Migraine;	chr10:103309363	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-4.86	1.78e-06	-0.2	-0.26	Migraine;	chr10:103367951	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-4.86	1.81e-06	-0.2	-0.26	Migraine;	chr10:103379204	chr10:103394301~103394322:-
LIHC	cis	rs10862219	0.762	rs4480600	MIMAT0003287	hsa-miR-618	4.85	1.85e-06	0.3	0.26	Neuroticism;	chr12:80987447	chr12:80935796~80935818:-
LIHC	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-4.85	1.89e-06	-0.28	-0.26	Migraine;	chr10:103384531	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-4.84	1.99e-06	-0.21	-0.25	Migraine;	chr10:103254113	chr10:103394301~103394322:-
LIHC	cis	rs59372292	0.597	rs34337793	MIMAT0021017	hsa-miR-4999-5p	4.84	2.02e-06	0.33	0.25	Coronary artery disease;	chr19:8454339	chr19:8389340~8389360:-
LIHC	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-4.84	2.02e-06	-0.2	-0.25	Migraine;	chr10:103395888	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	4.82	2.16e-06	0.26	0.25	Migraine;	chr10:103237257	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-4.82	2.21e-06	-0.2	-0.25	Migraine;	chr10:103353944	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-4.82	2.21e-06	-0.2	-0.25	Migraine;	chr10:103356299	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-4.81	2.24e-06	-0.2	-0.25	Migraine;	chr10:103358719	chr10:103394301~103394322:-
LIHC	cis	rs59372292	0.597	rs17160491	MIMAT0021017	hsa-miR-4999-5p	4.81	2.32e-06	0.34	0.25	Coronary artery disease;	chr19:8448056	chr19:8389340~8389360:-
LIHC	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	4.8	2.4e-06	0.21	0.25	Migraine;	chr10:103263177	chr10:103394301~103394322:-
LIHC	cis	rs75358501	0.551	rs13394079	MIMAT0014995	hsa-miR-3130-5p	-4.79	2.46e-06	-0.33	-0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.551	rs13394079	MIMAT0014995_1	hsa-miR-3130-5p	-4.79	2.46e-06	-0.33	-0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783246~206783266:+
LIHC	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	4.78	2.57e-06	0.19	0.25	Migraine;	chr10:103241753	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-4.78	2.66e-06	-0.27	-0.25	Migraine;	chr10:103358705	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	4.77	2.72e-06	0.2	0.25	Migraine;	chr10:103367830	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-4.77	2.72e-06	-0.2	-0.25	Migraine;	chr10:103367521	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-4.77	2.75e-06	-0.26	-0.25	Migraine;	chr10:103241568	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-4.77	2.8e-06	-0.27	-0.25	Migraine;	chr10:103386935	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-4.76	2.83e-06	-0.27	-0.25	Migraine;	chr10:103395309	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	4.75	3e-06	0.26	0.25	Migraine;	chr10:103241753	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	4.75	3.07e-06	0.26	0.25	Migraine;	chr10:103248169	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	4.75	3.07e-06	0.26	0.25	Migraine;	chr10:103249329	chr10:103394341~103394361:-
LIHC	cis	rs13390641	1	rs6707103	MIMAT0019927	hsa-miR-4772-3p	-4.74	3.12e-06	-0.37	-0.25	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103378053	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs12616040	MIMAT0019927	hsa-miR-4772-3p	-4.74	3.13e-06	-0.38	-0.25	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103384805	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-4.74	3.13e-06	-0.26	-0.25	Migraine;	chr10:103273871	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-4.73	3.23e-06	-0.27	-0.25	Migraine;	chr10:103367951	chr10:103394341~103394361:-
LIHC	cis	rs10862219	0.762	rs7299508	MIMAT0003287	hsa-miR-618	-4.73	3.24e-06	-0.29	-0.25	Neuroticism;	chr12:80996245	chr12:80935796~80935818:-
LIHC	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	4.73	3.33e-06	0.26	0.25	Migraine;	chr10:103238157	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-4.73	3.36e-06	-0.2	-0.25	Migraine;	chr10:103348698	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-4.72	3.41e-06	-0.27	-0.25	Migraine;	chr10:103353944	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-4.72	3.41e-06	-0.27	-0.25	Migraine;	chr10:103356299	chr10:103394341~103394361:-
LIHC	cis	rs10862219	0.762	rs2139731	MIMAT0003287	hsa-miR-618	-4.7	3.86e-06	-0.29	-0.25	Neuroticism;	chr12:80997555	chr12:80935796~80935818:-
LIHC	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-4.69	4.01e-06	-0.27	-0.25	Migraine;	chr10:103379204	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-4.67	4.34e-06	-0.27	-0.25	Migraine;	chr10:103358719	chr10:103394341~103394361:-
LIHC	cis	rs13390641	1	rs7567143	MIMAT0019927	hsa-miR-4772-3p	-4.67	4.38e-06	-0.37	-0.25	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103422800	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-4.66	4.62e-06	-0.26	-0.25	Migraine;	chr10:103395888	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-4.64	4.97e-06	-0.25	-0.24	Migraine;	chr10:103262005	chr10:103394341~103394361:-
LIHC	cis	rs13390641	1	rs67891378	MIMAT0019927	hsa-miR-4772-3p	-4.64	5.06e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103389051	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-4.63	5.24e-06	-0.26	-0.24	Migraine;	chr10:103367521	chr10:103394341~103394361:-
LIHC	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	4.63	5.24e-06	0.56	0.24	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
LIHC	cis	rs1712517	0.904	rs4918007	MIMAT0005951	hsa-miR-1307-3p	4.63	5.28e-06	0.19	0.24	Migraine;	chr10:103347713	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-4.62	5.51e-06	-0.26	-0.24	Migraine;	chr10:103348698	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-4.61	5.71e-06	-0.25	-0.24	Migraine;	chr10:103278698	chr10:103394341~103394361:-
LIHC	cis	rs13390641	1	rs67055500	MIMAT0019927	hsa-miR-4772-3p	-4.6	6.11e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103380065	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs72833503	MIMAT0019927	hsa-miR-4772-3p	-4.6	6.11e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103380118	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs67260601	MIMAT0019927	hsa-miR-4772-3p	-4.6	6.11e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103381081	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs67053500	MIMAT0019927	hsa-miR-4772-3p	-4.6	6.11e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103381482	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs7564824	MIMAT0019927	hsa-miR-4772-3p	-4.6	6.11e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103382186	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs1865144	MIMAT0019927	hsa-miR-4772-3p	-4.6	6.11e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103384527	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs58554240	MIMAT0019927	hsa-miR-4772-3p	-4.6	6.11e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103385680	chr2:102432336~102432357:+
LIHC	cis	rs453301	0.686	rs6601280	MIMAT0019728	hsa-miR-4660	4.59	6.17e-06	0.36	0.24	Joint mobility (Beighton score);	chr8:9051726	chr8:9048453~9048475:+
LIHC	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-4.58	6.47e-06	-0.19	-0.24	Migraine;	chr10:103375562	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.836	rs11191649	MIMAT0005951	hsa-miR-1307-3p	-4.58	6.5e-06	-0.19	-0.24	Migraine;	chr10:103307280	chr10:103394301~103394322:-
LIHC	cis	rs13390641	1	rs10496372	MIMAT0019927	hsa-miR-4772-3p	-4.58	6.69e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103403282	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.803	rs17028813	MIMAT0019927	hsa-miR-4772-3p	-4.58	6.69e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103403908	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs10210727	MIMAT0019927	hsa-miR-4772-3p	-4.57	6.73e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103414005	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs10193218	MIMAT0019927	hsa-miR-4772-3p	-4.57	6.73e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103416013	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.522	rs13417117	MIMAT0019927	hsa-miR-4772-3p	-4.57	6.73e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103417362	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs13390641	MIMAT0019927	hsa-miR-4772-3p	-4.57	6.73e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103419975	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs13396295	MIMAT0019927	hsa-miR-4772-3p	-4.57	6.73e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103424066	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs13383630	MIMAT0019927	hsa-miR-4772-3p	-4.57	6.73e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103424654	chr2:102432336~102432357:+
LIHC	cis	rs10862219	0.586	rs6539537	MIMAT0003287	hsa-miR-618	4.57	6.73e-06	0.3	0.24	Neuroticism;	chr12:80985846	chr12:80935796~80935818:-
LIHC	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-4.57	6.82e-06	-0.26	-0.24	Migraine;	chr10:103292867	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-4.57	6.82e-06	-0.26	-0.24	Migraine;	chr10:103293183	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-4.57	6.82e-06	-0.26	-0.24	Migraine;	chr10:103293219	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-4.56	7.09e-06	-0.19	-0.24	Migraine;	chr10:103284400	chr10:103394301~103394322:-
LIHC	cis	rs13390641	0.908	rs17028817	MIMAT0019927	hsa-miR-4772-3p	-4.56	7.16e-06	-0.36	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103404129	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-4.54	7.73e-06	-0.19	-0.24	Migraine;	chr10:103305652	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-4.54	7.94e-06	-0.25	-0.24	Migraine;	chr10:103279822	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	4.53	8.3e-06	0.24	0.24	Migraine;	chr10:103261506	chr10:103394341~103394361:-
LIHC	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	4.52	8.48e-06	0.26	0.24	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
LIHC	cis	rs59372292	0.667	rs3764570	MIMAT0021017	hsa-miR-4999-5p	4.51	8.81e-06	0.31	0.24	Coronary artery disease;	chr19:8463393	chr19:8389340~8389360:-
LIHC	cis	rs59372292	0.667	rs3794997	MIMAT0021017	hsa-miR-4999-5p	4.51	8.81e-06	0.31	0.24	Coronary artery disease;	chr19:8465003	chr19:8389340~8389360:-
LIHC	cis	rs59372292	0.667	rs34445564	MIMAT0021017	hsa-miR-4999-5p	4.51	8.85e-06	0.32	0.24	Coronary artery disease;	chr19:8468214	chr19:8389340~8389360:-
LIHC	cis	rs59372292	0.667	rs17159302	MIMAT0021017	hsa-miR-4999-5p	4.51	8.85e-06	0.32	0.24	Coronary artery disease;	chr19:8469632	chr19:8389340~8389360:-
LIHC	cis	rs59372292	0.667	rs17159303	MIMAT0021017	hsa-miR-4999-5p	4.51	8.85e-06	0.32	0.24	Coronary artery disease;	chr19:8469677	chr19:8389340~8389360:-
LIHC	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-4.51	8.9e-06	-0.26	-0.24	Migraine;	chr10:103299082	chr10:103394341~103394361:-
LIHC	cis	rs13390641	1	rs66472149	MIMAT0019927	hsa-miR-4772-3p	-4.51	8.98e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103389189	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs7558155	MIMAT0019927	hsa-miR-4772-3p	-4.51	8.98e-06	-0.37	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103389862	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-4.5	9.39e-06	-0.25	-0.24	Migraine;	chr10:103270083	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-4.49	9.57e-06	-0.19	-0.24	Migraine;	chr10:103389790	chr10:103394301~103394322:-
LIHC	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-4.49	9.88e-06	-0.26	-0.24	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
LIHC	cis	rs75358501	0.551	rs12471939	MIMAT0014995	hsa-miR-3130-5p	-4.47	1.05e-05	-0.31	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.551	rs12471939	MIMAT0014995_1	hsa-miR-3130-5p	-4.47	1.05e-05	-0.31	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783246~206783266:+
LIHC	cis	rs13390641	1	rs17028798	MIMAT0019927	hsa-miR-4772-3p	4.47	1.06e-05	0.34	0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103399988	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	4.47	1.08e-05	0.19	0.24	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
LIHC	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-4.46	1.1e-05	-0.26	-0.24	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
LIHC	cis	rs13390641	0.901	rs892264	MIMAT0019927	hsa-miR-4772-3p	-4.46	1.1e-05	-0.36	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103398249	chr2:102432336~102432357:+
LIHC	cis	rs61776719	0.52	rs12569027	MIMAT0022276	hsa-miR-5581-3p	4.46	1.12e-05	0.25	0.24	Coronary artery disease;	chr1:37983491	chr1:37500935~37500956:-
LIHC	cis	rs7072216	0.763	rs733345	MIMAT0026738	hsa-miR-1287-3p	4.46	1.12e-05	0.27	0.24	Metabolite levels;	chr10:98404458	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs733346	MIMAT0026738	hsa-miR-1287-3p	4.46	1.12e-05	0.27	0.24	Metabolite levels;	chr10:98404568	chr10:98395232~98395253:-
LIHC	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-4.46	1.13e-05	-0.26	-0.24	Migraine;	chr10:103289348	chr10:103394341~103394361:-
LIHC	cis	rs59372292	0.572	rs35279560	MIMAT0021017	hsa-miR-4999-5p	4.46	1.13e-05	0.31	0.24	Coronary artery disease;	chr19:8472212	chr19:8389340~8389360:-
LIHC	cis	rs13390641	1	rs17028778	MIMAT0019927	hsa-miR-4772-3p	-4.45	1.14e-05	-0.36	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103395714	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.901	rs55879317	MIMAT0019927	hsa-miR-4772-3p	-4.45	1.14e-05	-0.36	-0.24	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103396885	chr2:102432336~102432357:+
LIHC	cis	rs59372292	0.667	rs34244685	MIMAT0021017	hsa-miR-4999-5p	4.45	1.15e-05	0.31	0.24	Coronary artery disease;	chr19:8458122	chr19:8389340~8389360:-
LIHC	cis	rs2980436	1	rs2980436	MIMAT0019728	hsa-miR-4660	-4.45	1.16e-05	-0.32	-0.24	Schizophrenia;	chr8:8234503	chr8:9048453~9048475:+
LIHC	cis	rs13390641	1	rs67455729	MIMAT0019927	hsa-miR-4772-3p	-4.44	1.24e-05	-0.35	-0.23	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103403743	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.901	rs17028802	MIMAT0019927	hsa-miR-4772-3p	-4.44	1.24e-05	-0.35	-0.23	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103401323	chr2:102432336~102432357:+
LIHC	cis	rs11657217	0.638	rs4313839	MIMAT0019868	hsa-miR-4739	4.44	1.24e-05	0.25	0.23	Diastolic blood pressure response to hydrochlorothiazide in hypertension;	chr17:79724849	chr17:79707216~79707240:-
LIHC	cis	rs7072216	0.726	rs4474372	MIMAT0026738	hsa-miR-1287-3p	4.43	1.25e-05	0.27	0.23	Metabolite levels;	chr10:98404814	chr10:98395232~98395253:-
LIHC	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	4.43	1.27e-05	0.26	0.23	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
LIHC	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	4.43	1.27e-05	0.24	0.23	Migraine;	chr10:103244344	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.904	rs10883863	MIMAT0005951	hsa-miR-1307-3p	4.41	1.39e-05	0.18	0.23	Migraine;	chr10:103402122	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.873	rs7894240	MIMAT0022727	hsa-miR-1307-5p	4.41	1.39e-05	0.24	0.23	Migraine;	chr10:103240612	chr10:103394341~103394361:-
LIHC	cis	rs11657217	0.677	rs8071194	MIMAT0019868	hsa-miR-4739	-4.4	1.46e-05	-0.25	-0.23	Diastolic blood pressure response to hydrochlorothiazide in hypertension;	chr17:79724688	chr17:79707216~79707240:-
LIHC	cis	rs61776719	0.5	rs11210866	MIMAT0022276	hsa-miR-5581-3p	4.39	1.55e-05	0.25	0.23	Coronary artery disease;	chr1:37983893	chr1:37500935~37500956:-
LIHC	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	4.38	1.56e-05	0.28	0.23	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	4.38	1.56e-05	0.28	0.23	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	4.38	1.56e-05	0.28	0.23	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
LIHC	cis	rs61776719	0.875	rs10890238	MIMAT0022276	hsa-miR-5581-3p	4.38	1.6e-05	0.24	0.23	Coronary artery disease;	chr1:37979982	chr1:37500935~37500956:-
LIHC	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	4.37	1.62e-05	0.28	0.23	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
LIHC	cis	rs4072980	0.527	rs11210825	MIMAT0022276	hsa-miR-5581-3p	4.37	1.65e-05	0.25	0.23	Coronary artery disease;	chr1:37981314	chr1:37500935~37500956:-
LIHC	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	4.37	1.69e-05	0.27	0.23	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	4.37	1.69e-05	0.27	0.23	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
LIHC	cis	rs7894407	0.504	rs7089271	MIMAT0005951	hsa-miR-1307-3p	-4.36	1.74e-05	-0.18	-0.23	White matter hyperintensity burden;	chr10:103417157	chr10:103394301~103394322:-
LIHC	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	4.36	1.75e-05	0.27	0.23	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	4.36	1.75e-05	0.27	0.23	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	4.35	1.79e-05	0.28	0.23	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.727	rs7915108	MIMAT0026738	hsa-miR-1287-3p	4.35	1.83e-05	0.27	0.23	Metabolite levels;	chr10:98404684	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.727	rs7901577	MIMAT0026738	hsa-miR-1287-3p	4.35	1.83e-05	0.27	0.23	Metabolite levels;	chr10:98404685	chr10:98395232~98395253:-
LIHC	cis	rs75358501	0.551	rs79761690	MIMAT0014995	hsa-miR-3130-5p	-4.34	1.88e-05	-0.3	-0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.551	rs79761690	MIMAT0014995_1	hsa-miR-3130-5p	-4.34	1.88e-05	-0.3	-0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783246~206783266:+
LIHC	cis	rs75358501	0.551	rs28619220	MIMAT0014995	hsa-miR-3130-5p	-4.34	1.88e-05	-0.3	-0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.551	rs28619220	MIMAT0014995_1	hsa-miR-3130-5p	-4.34	1.88e-05	-0.3	-0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783246~206783266:+
LIHC	cis	rs13390641	1	rs12623415	MIMAT0019927	hsa-miR-4772-3p	-4.34	1.9e-05	-0.33	-0.23	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103371191	chr2:102432336~102432357:+
LIHC	cis	rs7072216	0.763	rs4475861	MIMAT0026738	hsa-miR-1287-3p	4.33	1.94e-05	0.26	0.23	Metabolite levels;	chr10:98405232	chr10:98395232~98395253:-
LIHC	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	4.33	1.96e-05	0.17	0.23	Migraine;	chr10:103237257	chr10:103394301~103394322:-
LIHC	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	4.32	2.04e-05	0.27	0.23	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
LIHC	cis	rs6120849	0.754	rs6120788	MIMAT0004772	hsa-miR-499a-3p	-4.32	2.07e-05	-0.33	-0.23	Protein C levels;	chr20:34995913	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs3746436	MIMAT0004772	hsa-miR-499a-3p	-4.32	2.07e-05	-0.33	-0.23	Protein C levels;	chr20:34998390	chr20:34990445~34990466:+
LIHC	cis	rs1712517	0.771	rs10883857	MIMAT0022727	hsa-miR-1307-5p	4.31	2.15e-05	0.25	0.23	Migraine;	chr10:103367830	chr10:103394341~103394361:-
LIHC	cis	rs6120849	0.754	rs3746435	MIMAT0004772	hsa-miR-499a-3p	-4.31	2.15e-05	-0.33	-0.23	Protein C levels;	chr20:34999395	chr20:34990445~34990466:+
LIHC	cis	rs17639215	0.55	rs4851003	MIMAT0019927	hsa-miR-4772-3p	-4.29	2.31e-05	-0.27	-0.23	Serum protein levels (sST2);	chr2:102292817	chr2:102432336~102432357:+
LIHC	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-4.29	2.35e-05	-0.26	-0.23	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
LIHC	cis	rs2695743	0.647	rs1344922	MIMAT0018962	hsa-miR-4444	-4.28	2.43e-05	-0.28	-0.23	Cough in response to angiotensin-converting enzyme inhibitor drugs;	chr2:177823807	chr2:177212768~177212785:+
LIHC	cis	rs2695743	0.647	rs1344922	MIMAT0018962_1	hsa-miR-4444	-4.28	2.43e-05	-0.28	-0.23	Cough in response to angiotensin-converting enzyme inhibitor drugs;	chr2:177823807	chr3:75214518~75214535:+
LIHC	cis	rs4574684	0.521	rs7760645	MIMAT0015015	hsa-miR-3144-3p	4.28	2.46e-05	0.24	0.23	Systemic lupus erythematosus;	chr6:120010962	chr6:120015226~120015247:+
LIHC	cis	rs11657217	0.677	rs8067469	MIMAT0019868	hsa-miR-4739	-4.27	2.54e-05	-0.25	-0.23	Diastolic blood pressure response to hydrochlorothiazide in hypertension;	chr17:79724552	chr17:79707216~79707240:-
LIHC	cis	rs2695743	0.647	rs6736927	MIMAT0018962	hsa-miR-4444	-4.27	2.56e-05	-0.28	-0.23	Cough in response to angiotensin-converting enzyme inhibitor drugs;	chr2:177824961	chr2:177212768~177212785:+
LIHC	cis	rs2695743	0.647	rs6736927	MIMAT0018962_1	hsa-miR-4444	-4.27	2.56e-05	-0.28	-0.23	Cough in response to angiotensin-converting enzyme inhibitor drugs;	chr2:177824961	chr3:75214518~75214535:+
LIHC	cis	rs13390641	1	rs10496370	MIMAT0019927	hsa-miR-4772-3p	-4.26	2.62e-05	-0.32	-0.23	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103400879	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-4.26	2.64e-05	-0.17	-0.23	Migraine;	chr10:103278698	chr10:103394301~103394322:-
LIHC	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	4.26	2.66e-05	0.19	0.23	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-4.26	2.7e-05	-0.18	-0.23	Migraine;	chr10:103292867	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-4.26	2.7e-05	-0.18	-0.23	Migraine;	chr10:103293183	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-4.26	2.7e-05	-0.18	-0.23	Migraine;	chr10:103293219	chr10:103394301~103394322:-
LIHC	cis	rs7624766	0.508	rs9831287	MIMAT0000417	hsa-miR-15b-5p	4.25	2.77e-05	0.21	0.23	Response to methotrexate in rheumatoid arthritis;	chr3:160861460	chr3:160404607~160404628:+
LIHC	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	4.25	2.79e-05	0.27	0.23	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
LIHC	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	4.25	2.8e-05	0.18	0.23	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-4.24	2.88e-05	-0.18	-0.22	Migraine;	chr10:103299082	chr10:103394301~103394322:-
LIHC	cis	rs7072216	0.763	rs10732782	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98406749	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.691	rs7910973	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98406975	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs7911036	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98407258	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs10883090	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98407479	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs45523432	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98407679	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs12763044	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98407694	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.727	rs942808	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98408345	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.727	rs942807	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98408462	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs942805	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98408615	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	4.24	2.9e-05	0.26	0.22	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
LIHC	cis	rs2695743	0.647	rs1946814	MIMAT0018962	hsa-miR-4444	-4.23	3e-05	-0.27	-0.22	Cough in response to angiotensin-converting enzyme inhibitor drugs;	chr2:177814949	chr2:177212768~177212785:+
LIHC	cis	rs2695743	0.647	rs1946814	MIMAT0018962_1	hsa-miR-4444	-4.23	3e-05	-0.27	-0.22	Cough in response to angiotensin-converting enzyme inhibitor drugs;	chr2:177814949	chr3:75214518~75214535:+
LIHC	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	4.23	3.03e-05	0.27	0.22	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
LIHC	cis	rs2695743	0.647	rs13424417	MIMAT0018962	hsa-miR-4444	-4.23	3.03e-05	-0.27	-0.22	Cough in response to angiotensin-converting enzyme inhibitor drugs;	chr2:177802270	chr2:177212768~177212785:+
LIHC	cis	rs2695743	0.647	rs13424417	MIMAT0018962_1	hsa-miR-4444	-4.23	3.03e-05	-0.27	-0.22	Cough in response to angiotensin-converting enzyme inhibitor drugs;	chr2:177802270	chr3:75214518~75214535:+
LIHC	cis	rs6120849	0.708	rs6087659	MIMAT0004772	hsa-miR-499a-3p	-4.23	3.07e-05	-0.32	-0.22	Protein C levels;	chr20:35018580	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.663	rs6088662	MIMAT0004772	hsa-miR-499a-3p	-4.22	3.11e-05	-0.3	-0.22	Protein C levels;	chr20:34959830	chr20:34990445~34990466:+
LIHC	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	4.21	3.22e-05	0.27	0.22	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
LIHC	cis	rs10862219	0.642	rs4842373	MIMAT0003287	hsa-miR-618	4.21	3.22e-05	0.27	0.22	Neuroticism;	chr12:80997171	chr12:80935796~80935818:-
LIHC	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	4.21	3.24e-05	0.26	0.22	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs942804	MIMAT0026738	hsa-miR-1287-3p	4.21	3.24e-05	0.26	0.22	Metabolite levels;	chr10:98408742	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.65	rs10883089	MIMAT0026738	hsa-miR-1287-3p	4.21	3.29e-05	0.26	0.22	Metabolite levels;	chr10:98403363	chr10:98395232~98395253:-
LIHC	cis	rs6120849	0.615	rs11167248	MIMAT0004772	hsa-miR-499a-3p	-4.21	3.31e-05	-0.3	-0.22	Protein C levels;	chr20:34950918	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.586	rs2025096	MIMAT0004772	hsa-miR-499a-3p	-4.21	3.31e-05	-0.3	-0.22	Protein C levels;	chr20:34952197	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6088678	MIMAT0004772	hsa-miR-499a-3p	4.2	3.36e-05	0.32	0.22	Protein C levels;	chr20:35019748	chr20:34990445~34990466:+
LIHC	cis	rs61776719	0.738	rs7555461	MIMAT0022276	hsa-miR-5581-3p	-4.2	3.41e-05	-0.24	-0.22	Coronary artery disease;	chr1:37979077	chr1:37500935~37500956:-
LIHC	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-4.2	3.49e-05	-0.17	-0.22	Migraine;	chr10:103273985	chr10:103394301~103394322:-
LIHC	cis	rs7072216	0.922	rs4488133	MIMAT0026738	hsa-miR-1287-3p	-4.19	3.56e-05	-0.25	-0.22	Metabolite levels;	chr10:98399379	chr10:98395232~98395253:-
LIHC	cis	rs1075265	0.783	rs6708095	MIMAT0018110	hsa-miR-3682-3p	-4.19	3.56e-05	-0.23	-0.22	Chronotype;Morning vs. evening chronotype;	chr2:53710365	chr2:53849136~53849156:-
LIHC	cis	rs13390641	1	rs10168650	MIMAT0019927	hsa-miR-4772-3p	4.19	3.56e-05	0.34	0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103411386	chr2:102432336~102432357:+
LIHC	cis	rs3746446	0.678	rs6120777	MIMAT0004772	hsa-miR-499a-3p	-4.19	3.6e-05	-0.34	-0.22	Congenital left-sided heart lesions;	chr20:34972369	chr20:34990445~34990466:+
LIHC	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	4.19	3.61e-05	0.26	0.22	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs9787550	MIMAT0026738	hsa-miR-1287-3p	4.19	3.61e-05	0.26	0.22	Metabolite levels;	chr10:98409294	chr10:98395232~98395253:-
LIHC	cis	rs13390641	1	rs74703351	MIMAT0019927	hsa-miR-4772-3p	-4.18	3.65e-05	-0.32	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103374067	chr2:102432336~102432357:+
LIHC	cis	rs7072216	1	rs7072216	MIMAT0026738	hsa-miR-1287-3p	4.18	3.69e-05	0.25	0.22	Metabolite levels;	chr10:98397096	chr10:98395232~98395253:-
LIHC	cis	rs6120849	0.754	rs7268266	MIMAT0004772	hsa-miR-499a-3p	-4.18	3.71e-05	-0.32	-0.22	Protein C levels;	chr20:34994086	chr20:34990445~34990466:+
LIHC	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	4.18	3.72e-05	0.18	0.22	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
LIHC	cis	rs6120849	0.754	rs3746446	MIMAT0004772	hsa-miR-499a-3p	-4.18	3.74e-05	-0.32	-0.22	Protein C levels;	chr20:34986962	chr20:34990445~34990466:+
LIHC	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-4.18	3.75e-05	-0.18	-0.22	Migraine;	chr10:103289348	chr10:103394301~103394322:-
LIHC	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	4.17	3.8e-05	0.26	0.22	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
LIHC	cis	rs13390641	1	rs6710847	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.85e-05	-0.32	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103391121	chr2:102432336~102432357:+
LIHC	cis	rs11186	0.749	rs72906383	MIMAT0019202	hsa-miR-3129-3p	4.17	3.86e-05	0.44	0.22	Parkinson's disease;	chr2:189101758	chr2:189133044~189133065:-
LIHC	cis	rs6120849	0.754	rs36003887	MIMAT0004772	hsa-miR-499a-3p	-4.17	3.87e-05	-0.32	-0.22	Protein C levels;	chr20:35001304	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs8501	MIMAT0004772	hsa-miR-499a-3p	-4.17	3.87e-05	-0.32	-0.22	Protein C levels;	chr20:35002781	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.707	rs752075	MIMAT0004772	hsa-miR-499a-3p	-4.17	3.87e-05	-0.32	-0.22	Protein C levels;	chr20:35003788	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs752448	MIMAT0004772	hsa-miR-499a-3p	-4.17	3.87e-05	-0.32	-0.22	Protein C levels;	chr20:35004445	chr20:34990445~34990466:+
LIHC	cis	rs1712517	0.838	rs1891293	MIMAT0022727	hsa-miR-1307-5p	4.17	3.89e-05	0.23	0.22	Migraine;	chr10:103242040	chr10:103394341~103394361:-
LIHC	cis	rs1075265	0.744	rs2909460	MIMAT0018110	hsa-miR-3682-3p	-4.16	3.97e-05	-0.23	-0.22	Chronotype;Morning vs. evening chronotype;	chr2:53967611	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.811	rs805308	MIMAT0018110	hsa-miR-3682-3p	-4.16	3.97e-05	-0.23	-0.22	Chronotype;Morning vs. evening chronotype;	chr2:53967797	chr2:53849136~53849156:-
LIHC	cis	rs11657217	0.502	rs4442854	MIMAT0019868	hsa-miR-4739	-4.16	4.02e-05	-0.24	-0.22	Diastolic blood pressure response to hydrochlorothiazide in hypertension;	chr17:79724454	chr17:79707216~79707240:-
LIHC	cis	rs7138951	0.636	rs7959125	MIMAT0003287	hsa-miR-618	4.16	4.05e-05	0.3	0.22	Plasma amyloid beta peptide concentrations (ABx-42);	chr12:81081385	chr12:80935796~80935818:-
LIHC	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-4.16	4.06e-05	-0.24	-0.22	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
LIHC	cis	rs6120849	0.951	rs55670307	MIMAT0004772	hsa-miR-499a-3p	-4.15	4.13e-05	-0.35	-0.22	Protein C levels;	chr20:35132691	chr20:34990445~34990466:+
LIHC	cis	rs1075265	0.704	rs10181999	MIMAT0018110	hsa-miR-3682-3p	-4.15	4.18e-05	-0.22	-0.22	Chronotype;Morning vs. evening chronotype;	chr2:54025360	chr2:53849136~53849156:-
LIHC	cis	rs6120849	0.707	rs6120826	MIMAT0004772	hsa-miR-499a-3p	-4.15	4.2e-05	-0.32	-0.22	Protein C levels;	chr20:35084028	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6120828	MIMAT0004772	hsa-miR-499a-3p	-4.15	4.2e-05	-0.32	-0.22	Protein C levels;	chr20:35086657	chr20:34990445~34990466:+
LIHC	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-4.15	4.24e-05	-0.23	-0.22	Migraine;	chr10:103283532	chr10:103394341~103394361:-
LIHC	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-4.15	4.24e-05	-0.23	-0.22	Migraine;	chr10:103284207	chr10:103394341~103394361:-
LIHC	cis	rs1075265	0.756	rs2160931	MIMAT0018110	hsa-miR-3682-3p	-4.15	4.3e-05	-0.23	-0.22	Chronotype;Morning vs. evening chronotype;	chr2:53712411	chr2:53849136~53849156:-
LIHC	cis	rs17730929	1	rs17087196	MIMAT0005923	hsa-miR-1269a	4.14	4.32e-05	0.55	0.22	Colorectal cancer (SNP x SNP interaction);	chr4:66482161	chr4:66276890~66276911:+
LIHC	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-4.14	4.48e-05	-0.26	-0.22	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
LIHC	cis	rs6120849	0.754	rs1885116	MIMAT0004772	hsa-miR-499a-3p	-4.13	4.52e-05	-0.31	-0.22	Protein C levels;	chr20:35012757	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs1885117	MIMAT0004772	hsa-miR-499a-3p	-4.13	4.52e-05	-0.31	-0.22	Protein C levels;	chr20:35012937	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6120797	MIMAT0004772	hsa-miR-499a-3p	-4.13	4.54e-05	-0.31	-0.22	Protein C levels;	chr20:35018199	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6119560	MIMAT0004772	hsa-miR-499a-3p	-4.13	4.54e-05	-0.31	-0.22	Protein C levels;	chr20:35019174	chr20:34990445~34990466:+
LIHC	cis	rs941898	0.541	rs1951486	MIMAT0003180	hsa-miR-487b-3p	4.12	4.71e-05	0.13	0.22	White matter hyperintensity burden;	chr14:100141023	chr14:101046505~101046526:+
LIHC	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-4.12	4.71e-05	-0.24	-0.22	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
LIHC	cis	rs7072216	0.922	rs10786415	MIMAT0026738	hsa-miR-1287-3p	4.12	4.72e-05	0.25	0.22	Metabolite levels;	chr10:98391509	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.922	rs942814	MIMAT0026738	hsa-miR-1287-3p	4.12	4.72e-05	0.25	0.22	Metabolite levels;	chr10:98391548	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.922	rs6584191	MIMAT0026738	hsa-miR-1287-3p	4.12	4.72e-05	0.25	0.22	Metabolite levels;	chr10:98392298	chr10:98395232~98395253:-
LIHC	cis	rs6120849	0.754	rs6088686	MIMAT0004772	hsa-miR-499a-3p	-4.12	4.74e-05	-0.32	-0.22	Protein C levels;	chr20:35035634	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6120804	MIMAT0004772	hsa-miR-499a-3p	-4.12	4.74e-05	-0.32	-0.22	Protein C levels;	chr20:35035898	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6120812	MIMAT0004772	hsa-miR-499a-3p	-4.12	4.74e-05	-0.32	-0.22	Protein C levels;	chr20:35041624	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.707	rs6088690	MIMAT0004772	hsa-miR-499a-3p	-4.12	4.74e-05	-0.32	-0.22	Protein C levels;	chr20:35045523	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6088691	MIMAT0004772	hsa-miR-499a-3p	-4.12	4.74e-05	-0.32	-0.22	Protein C levels;	chr20:35045955	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.518	rs11696652	MIMAT0004772	hsa-miR-499a-3p	-4.12	4.74e-05	-0.32	-0.22	Protein C levels;	chr20:35049257	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6087666	MIMAT0004772	hsa-miR-499a-3p	-4.12	4.74e-05	-0.32	-0.22	Protein C levels;	chr20:35052439	chr20:34990445~34990466:+
LIHC	cis	rs6005551	0.512	rs55952601	MIMAT0015084	hsa-miR-3199	-4.12	4.75e-05	-0.44	-0.22	Facial depth;	chr22:27648269	chr22:27920581~27920603:-
LIHC	cis	rs6005551	0.512	rs55952601	MIMAT0015084_1	hsa-miR-3199	-4.12	4.75e-05	-0.44	-0.22	Facial depth;	chr22:27648269	chr22:27920535~27920557:+
LIHC	cis	rs6120849	0.754	rs6120819	MIMAT0004772	hsa-miR-499a-3p	-4.12	4.87e-05	-0.32	-0.22	Protein C levels;	chr20:35065235	chr20:34990445~34990466:+
LIHC	cis	rs13390641	0.901	rs7566100	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.04e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103407411	chr2:102432336~102432357:+
LIHC	cis	rs7147624	0.572	rs2411813	MIMAT0004808	hsa-miR-625-3p	4.11	5.04e-05	0.36	0.22	Chronic obstructive pulmonary disease-related biomarkers;	chr14:65557188	chr14:65471153~65471174:+
LIHC	cis	rs1075265	0.722	rs7596349	MIMAT0018110	hsa-miR-3682-3p	-4.1	5.1e-05	-0.23	-0.22	Chronotype;Morning vs. evening chronotype;	chr2:53709123	chr2:53849136~53849156:-
LIHC	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	4.1	5.17e-05	0.26	0.22	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	4.1	5.17e-05	0.26	0.22	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
LIHC	cis	rs6120849	0.707	rs6120798	MIMAT0004772	hsa-miR-499a-3p	-4.1	5.21e-05	-0.31	-0.22	Protein C levels;	chr20:35023019	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs11167253	MIMAT0004772	hsa-miR-499a-3p	-4.1	5.21e-05	-0.31	-0.22	Protein C levels;	chr20:35026646	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.707	rs6120799	MIMAT0004772	hsa-miR-499a-3p	-4.1	5.21e-05	-0.31	-0.22	Protein C levels;	chr20:35027152	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6088682	MIMAT0004772	hsa-miR-499a-3p	-4.1	5.21e-05	-0.31	-0.22	Protein C levels;	chr20:35027899	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs13433216	MIMAT0004772	hsa-miR-499a-3p	-4.1	5.21e-05	-0.31	-0.22	Protein C levels;	chr20:35028498	chr20:34990445~34990466:+
LIHC	cis	rs13390641	1	rs7582966	MIMAT0019927	hsa-miR-4772-3p	-4.1	5.21e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103401605	chr2:102432336~102432357:+
LIHC	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-4.1	5.24e-05	-0.16	-0.22	Migraine;	chr10:103273258	chr10:103394301~103394322:-
LIHC	cis	rs11671005	0.735	rs12977592	MIMAT0027513	hsa-miR-6806-3p	4.1	5.28e-05	0.33	0.22	Mean platelet volume;	chr19:58449689	chr19:58334730~58334751:+
LIHC	cis	rs7072216	0.763	rs7914401	MIMAT0026738	hsa-miR-1287-3p	4.1	5.29e-05	0.25	0.22	Metabolite levels;	chr10:98404171	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	4.09	5.3e-05	0.26	0.22	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	4.09	5.3e-05	0.26	0.22	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
LIHC	cis	rs7937682	1	rs12363179	MIMAT0004676	hsa-miR-34b-3p	4.09	5.5e-05	0.34	0.22	Primary sclerosing cholangitis;	chr11:111697367	chr11:111512987~111513008:+
LIHC	cis	rs7937682	1	rs7121011	MIMAT0004676	hsa-miR-34b-3p	4.09	5.5e-05	0.34	0.22	Primary sclerosing cholangitis;	chr11:111697957	chr11:111512987~111513008:+
LIHC	cis	rs7937682	1	rs10502147	MIMAT0004676	hsa-miR-34b-3p	4.09	5.5e-05	0.34	0.22	Primary sclerosing cholangitis;	chr11:111699207	chr11:111512987~111513008:+
LIHC	cis	rs6120849	0.707	rs6088694	MIMAT0004772	hsa-miR-499a-3p	-4.08	5.55e-05	-0.31	-0.22	Protein C levels;	chr20:35064568	chr20:34990445~34990466:+
LIHC	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	4.08	5.59e-05	0.26	0.22	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.655	rs3830025	MIMAT0026738	hsa-miR-1287-3p	4.08	5.6e-05	0.27	0.22	Metabolite levels;	chr10:98416347	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.655	rs3830024	MIMAT0026738	hsa-miR-1287-3p	4.08	5.6e-05	0.27	0.22	Metabolite levels;	chr10:98416349	chr10:98395232~98395253:-
LIHC	cis	rs1075265	0.518	rs13414393	MIMAT0018110	hsa-miR-3682-3p	-4.08	5.65e-05	-0.22	-0.22	Chronotype;Morning vs. evening chronotype;	chr2:54048025	chr2:53849136~53849156:-
LIHC	cis	rs6120849	0.754	rs6120813	MIMAT0004772	hsa-miR-499a-3p	-4.08	5.65e-05	-0.31	-0.22	Protein C levels;	chr20:35054309	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs17319032	MIMAT0004772	hsa-miR-499a-3p	-4.08	5.65e-05	-0.31	-0.22	Protein C levels;	chr20:35055493	chr20:34990445~34990466:+
LIHC	cis	rs13390641	1	rs72833528	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.32	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103411695	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs10186758	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.32	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103414182	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs13409322	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.32	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103417575	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.803	rs17028859	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.32	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103421387	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs13421017	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.32	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103421445	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.803	rs13389258	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.32	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103422163	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs10496369	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103367569	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.614	rs55642095	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103367585	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.708	rs17028731	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103367840	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.901	rs17028733	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103368031	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs17028736	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103368093	chr2:102432336~102432357:+
LIHC	cis	rs13390641	0.614	rs1433311	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103369200	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs7575602	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103369527	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs7589442	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103369749	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs56217928	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103370270	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs1433312	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103370677	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs1433313	MIMAT0019927	hsa-miR-4772-3p	-4.08	5.74e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103370751	chr2:102432336~102432357:+
LIHC	cis	rs6120849	0.754	rs6087667	MIMAT0004772	hsa-miR-499a-3p	-4.07	5.94e-05	-0.31	-0.22	Protein C levels;	chr20:35064084	chr20:34990445~34990466:+
LIHC	cis	rs13390641	1	rs58862114	MIMAT0019927	hsa-miR-4772-3p	-4.06	6.04e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103371592	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs12622124	MIMAT0019927	hsa-miR-4772-3p	-4.06	6.04e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103372633	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs12612179	MIMAT0019927	hsa-miR-4772-3p	-4.06	6.04e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103372855	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs12612180	MIMAT0019927	hsa-miR-4772-3p	-4.06	6.04e-05	-0.31	-0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103372864	chr2:102432336~102432357:+
LIHC	cis	rs6120849	0.663	rs13041792	MIMAT0004772	hsa-miR-499a-3p	-4.06	6.07e-05	-0.29	-0.22	Protein C levels;	chr20:34957252	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6120793	MIMAT0004772	hsa-miR-499a-3p	-4.06	6.11e-05	-0.31	-0.22	Protein C levels;	chr20:35016604	chr20:34990445~34990466:+
LIHC	cis	rs7937682	0.924	rs6589244	MIMAT0004676	hsa-miR-34b-3p	-4.06	6.15e-05	-0.33	-0.22	Primary sclerosing cholangitis;	chr11:111663609	chr11:111512987~111513008:+
LIHC	cis	rs7937682	1	rs2186839	MIMAT0004676	hsa-miR-34b-3p	-4.06	6.15e-05	-0.33	-0.22	Primary sclerosing cholangitis;	chr11:111663718	chr11:111512987~111513008:+
LIHC	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-4.06	6.17e-05	-0.16	-0.22	Migraine;	chr10:103279291	chr10:103394301~103394322:-
LIHC	cis	rs13390641	1	rs17028739	MIMAT0019927	hsa-miR-4772-3p	4.06	6.17e-05	0.3	0.22	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103368452	chr2:102432336~102432357:+
LIHC	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	4.06	6.2e-05	0.25	0.22	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
LIHC	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.26e-05	-0.23	-0.22	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
LIHC	cis	rs1075265	0.73	rs4413193	MIMAT0018110	hsa-miR-3682-3p	-4.05	6.35e-05	-0.22	-0.22	Chronotype;Morning vs. evening chronotype;	chr2:53710901	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.704	rs10084374	MIMAT0018110	hsa-miR-3682-3p	-4.05	6.47e-05	-0.21	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:54022175	chr2:53849136~53849156:-
LIHC	cis	rs11671005	0.695	rs12972898	MIMAT0027513	hsa-miR-6806-3p	4.04	6.55e-05	0.35	0.21	Mean platelet volume;	chr19:58445521	chr19:58334730~58334751:+
LIHC	cis	rs1075265	0.84	rs805309	MIMAT0018110	hsa-miR-3682-3p	-4.04	6.55e-05	-0.23	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53968877	chr2:53849136~53849156:-
LIHC	cis	rs10503709	0.896	rs7010418	MIMAT0000510	hsa-miR-320a-3p	-4.04	6.57e-05	-0.18	-0.21	Blood protein levels;	chr8:21604069	chr8:22244975~22244996:-
LIHC	cis	rs6120849	0.617	rs12480442	MIMAT0004772	hsa-miR-499a-3p	-4.04	6.62e-05	-0.31	-0.21	Protein C levels;	chr20:35060585	chr20:34990445~34990466:+
LIHC	cis	rs13390641	1	rs7426175	MIMAT0019927	hsa-miR-4772-3p	-4.04	6.64e-05	-0.31	-0.21	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103424266	chr2:102432336~102432357:+
LIHC	cis	rs1075265	0.73	rs2111868	MIMAT0018110	hsa-miR-3682-3p	-4.03	6.88e-05	-0.22	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53958916	chr2:53849136~53849156:-
LIHC	cis	rs6120849	0.707	rs6088703	MIMAT0004772	hsa-miR-499a-3p	-4.03	6.93e-05	-0.31	-0.21	Protein C levels;	chr20:35088246	chr20:34990445~34990466:+
LIHC	cis	rs7072216	0.922	rs4539242	MIMAT0026738	hsa-miR-1287-3p	4.03	6.95e-05	0.24	0.21	Metabolite levels;	chr10:98388301	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.881	rs2147896	MIMAT0026738	hsa-miR-1287-3p	4.03	6.95e-05	0.24	0.21	Metabolite levels;	chr10:98388419	chr10:98395232~98395253:-
LIHC	cis	rs7937682	0.961	rs7119563	MIMAT0004676	hsa-miR-34b-3p	4.02	7.13e-05	0.34	0.21	Primary sclerosing cholangitis;	chr11:111673192	chr11:111512987~111513008:+
LIHC	cis	rs13390641	1	rs13391614	MIMAT0019927	hsa-miR-4772-3p	-4.02	7.23e-05	-0.32	-0.21	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103427383	chr2:102432336~102432357:+
LIHC	cis	rs16862782	1	rs16862782	MIMAT0000085	hsa-miR-28-5p	4.01	7.35e-05	0.27	0.21	Myopia (pathological);	chr3:187970102	chr3:188688794~188688815:+
LIHC	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-4.01	7.58e-05	-0.23	-0.21	Migraine;	chr10:103307280	chr10:103394341~103394361:-
LIHC	cis	rs59372292	0.642	rs1599870	MIMAT0021017	hsa-miR-4999-5p	4.01	7.59e-05	0.28	0.21	Coronary artery disease;	chr19:8488516	chr19:8389340~8389360:-
LIHC	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-4	7.67e-05	-0.25	-0.21	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.843	rs4400721	MIMAT0026738	hsa-miR-1287-3p	4	7.77e-05	0.24	0.21	Metabolite levels;	chr10:98387340	chr10:98395232~98395253:-
LIHC	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-4	7.82e-05	-0.23	-0.21	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
LIHC	cis	rs13390641	1	rs10188149	MIMAT0019927	hsa-miR-4772-3p	-4	7.94e-05	-0.3	-0.21	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103429976	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-3.99	8.15e-05	-0.23	-0.21	Migraine;	chr10:103305652	chr10:103394341~103394361:-
LIHC	cis	rs59372292	0.667	rs17160520	MIMAT0021017	hsa-miR-4999-5p	-3.99	8.16e-05	-0.28	-0.21	Coronary artery disease;	chr19:8483705	chr19:8389340~8389360:-
LIHC	cis	rs1075265	0.783	rs805450	MIMAT0018110	hsa-miR-3682-3p	-3.99	8.19e-05	-0.22	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53951772	chr2:53849136~53849156:-
LIHC	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	3.98	8.45e-05	0.17	0.21	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	3.98	8.45e-05	0.17	0.21	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
LIHC	cis	rs1075265	0.716	rs7573991	MIMAT0018110	hsa-miR-3682-3p	-3.98	8.5e-05	-0.22	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53726830	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.655	rs13432632	MIMAT0018110	hsa-miR-3682-3p	-3.97	8.61e-05	-0.22	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53713586	chr2:53849136~53849156:-
LIHC	cis	rs6120849	0.754	rs3818253	MIMAT0004772	hsa-miR-499a-3p	-3.97	8.76e-05	-0.3	-0.21	Protein C levels;	chr20:35009073	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.754	rs6120790	MIMAT0004772	hsa-miR-499a-3p	-3.97	8.76e-05	-0.3	-0.21	Protein C levels;	chr20:35011287	chr20:34990445~34990466:+
LIHC	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	3.97	8.79e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
LIHC	cis	rs7937682	0.889	rs12360825	MIMAT0004676	hsa-miR-34b-3p	-3.97	8.83e-05	-0.32	-0.21	Primary sclerosing cholangitis;	chr11:111658062	chr11:111512987~111513008:+
LIHC	cis	rs7937682	1	rs11608149	MIMAT0004676	hsa-miR-34b-3p	3.97	8.91e-05	0.33	0.21	Primary sclerosing cholangitis;	chr11:111664378	chr11:111512987~111513008:+
LIHC	cis	rs7937682	1	rs11608122	MIMAT0004676	hsa-miR-34b-3p	3.96	9.06e-05	0.33	0.21	Primary sclerosing cholangitis;	chr11:111664381	chr11:111512987~111513008:+
LIHC	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-3.96	9.27e-05	-0.23	-0.21	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
LIHC	cis	rs1075265	0.84	rs2884254	MIMAT0018110	hsa-miR-3682-3p	-3.95	9.37e-05	-0.22	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53979326	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.589	rs2253760	MIMAT0018110	hsa-miR-3682-3p	-3.95	9.68e-05	-0.21	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53806851	chr2:53849136~53849156:-
LIHC	cis	rs13390641	1	rs1013776	MIMAT0019927	hsa-miR-4772-3p	3.95	9.68e-05	0.31	0.21	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103413745	chr2:102432336~102432357:+
LIHC	cis	rs7072216	0.763	rs12763326	MIMAT0026738	hsa-miR-1287-3p	-3.94	9.75e-05	-0.25	-0.21	Metabolite levels;	chr10:98407639	chr10:98395232~98395253:-
LIHC	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	3.94	9.83e-05	0.38	0.21	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	3.94	9.83e-05	0.38	0.21	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
LIHC	cis	rs1075265	0.722	rs2111623	MIMAT0018110	hsa-miR-3682-3p	3.94	9.85e-05	0.21	0.21	Chronotype;Morning vs. evening chronotype;	chr2:53757820	chr2:53849136~53849156:-
LIHC	cis	rs10862219	0.642	rs10862215	MIMAT0003287	hsa-miR-618	3.94	9.87e-05	0.26	0.21	Neuroticism;	chr12:80998199	chr12:80935796~80935818:-
LIHC	cis	rs7937682	1	rs9734135	MIMAT0004676	hsa-miR-34b-3p	-3.94	9.88e-05	-0.31	-0.21	Primary sclerosing cholangitis;	chr11:111665466	chr11:111512987~111513008:+
LIHC	cis	rs11186	0.841	rs13392501	MIMAT0019202	hsa-miR-3129-3p	-3.94	9.96e-05	-0.42	-0.21	Parkinson's disease;	chr2:189042950	chr2:189133044~189133065:-
LIHC	cis	rs1075265	0.783	rs805453	MIMAT0018110	hsa-miR-3682-3p	-3.94	9.96e-05	-0.22	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53955761	chr2:53849136~53849156:-
LIHC	cis	rs74233809	0.748	rs10786736	MIMAT0022727	hsa-miR-1307-5p	-3.93	0.000101	-0.3	-0.21	Birth weight;	chr10:103089359	chr10:103394341~103394361:-
LIHC	cis	rs7894407	1	rs7894407	MIMAT0005951	hsa-miR-1307-3p	3.93	0.000102	0.17	0.21	White matter hyperintensity burden;	chr10:103416422	chr10:103394301~103394322:-
LIHC	cis	rs13390641	1	rs2069023	MIMAT0019927	hsa-miR-4772-3p	-3.93	0.000103	-0.3	-0.21	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103431961	chr2:102432336~102432357:+
LIHC	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-3.93	0.000103	-0.23	-0.21	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
LIHC	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-3.93	0.000103	-0.16	-0.21	Migraine;	chr10:103270083	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	3.93	0.000103	0.16	0.21	Migraine;	chr10:103248169	chr10:103394301~103394322:-
LIHC	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	3.93	0.000103	0.16	0.21	Migraine;	chr10:103249329	chr10:103394301~103394322:-
LIHC	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	3.93	0.000104	0.26	0.21	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
LIHC	cis	rs16985179	1	rs16985179	MIMAT0015084	hsa-miR-3199	-3.93	0.000104	-0.41	-0.21	Alcohol consumption;	chr22:27633571	chr22:27920581~27920603:-
LIHC	cis	rs16985179	1	rs16985179	MIMAT0015084_1	hsa-miR-3199	-3.93	0.000104	-0.41	-0.21	Alcohol consumption;	chr22:27633571	chr22:27920535~27920557:+
LIHC	cis	rs10862219	0.507	rs767850	MIMAT0003287	hsa-miR-618	3.92	0.000105	0.26	0.21	Neuroticism;	chr12:81001374	chr12:80935796~80935818:-
LIHC	cis	rs10862219	0.642	rs1987001	MIMAT0003287	hsa-miR-618	3.92	0.000105	0.26	0.21	Neuroticism;	chr12:81001413	chr12:80935796~80935818:-
LIHC	cis	rs34305371	0.584	rs4348675	MIMAT0000456	hsa-miR-186-5p	-3.92	0.000105	-0.35	-0.21	Educational attainment (years of education);Educational attainment (college completion);Cognitive ability;Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);	chr1:72050034	chr1:71067681~71067702:-
LIHC	cis	rs1075265	0.589	rs2542571	MIMAT0018110	hsa-miR-3682-3p	-3.92	0.000106	-0.2	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53814846	chr2:53849136~53849156:-
LIHC	cis	rs1559040	0.932	rs28368466	MIMAT0018110	hsa-miR-3682-3p	-3.92	0.000106	-0.35	-0.21	Sudden cardiac arrest;	chr2:54061824	chr2:53849136~53849156:-
LIHC	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-3.92	0.000106	-0.23	-0.21	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
LIHC	cis	rs6120849	0.707	rs3746444	MIMAT0004772	hsa-miR-499a-3p	-3.92	0.000109	-0.29	-0.21	Protein C levels;	chr20:34990448	chr20:34990445~34990466:+
LIHC	cis	rs7829975	0.56	rs17154599	MIMAT0019728	hsa-miR-4660	-3.92	0.000109	-0.28	-0.21	Mood instability;	chr8:8693908	chr8:9048453~9048475:+
LIHC	cis	rs7072216	0.922	rs59667296	MIMAT0026738	hsa-miR-1287-3p	3.91	0.00011	0.23	0.21	Metabolite levels;	chr10:98386556	chr10:98395232~98395253:-
LIHC	cis	rs6120849	0.663	rs11698868	MIMAT0004772	hsa-miR-499a-3p	-3.91	0.000113	-0.28	-0.21	Protein C levels;	chr20:34962143	chr20:34990445~34990466:+
LIHC	cis	rs6120849	0.663	rs6119548	MIMAT0004772	hsa-miR-499a-3p	-3.91	0.000113	-0.28	-0.21	Protein C levels;	chr20:34964809	chr20:34990445~34990466:+
LIHC	cis	rs7937682	1	rs7128353	MIMAT0004676	hsa-miR-34b-3p	-3.9	0.000114	-0.31	-0.21	Primary sclerosing cholangitis;	chr11:111668151	chr11:111512987~111513008:+
LIHC	cis	rs1075265	0.522	rs7584474	MIMAT0018110	hsa-miR-3682-3p	-3.9	0.000116	-0.21	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53674874	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.547	rs7587217	MIMAT0018110	hsa-miR-3682-3p	-3.9	0.000116	-0.21	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53675029	chr2:53849136~53849156:-
LIHC	cis	rs17060993	0.618	rs17056484	MIMAT0027587	hsa-miR-6842-3p	-3.9	0.000116	-0.36	-0.21	Musician's dystonia;	chr8:26990811	chr8:27433413~27433434:+
LIHC	cis	rs941898	0.625	rs3783330	MIMAT0003163	hsa-miR-539-5p	-3.9	0.000117	-0.15	-0.21	White matter hyperintensity burden;	chr14:100106617	chr14:101047329~101047350:+
LIHC	cis	rs13390641	1	rs10191343	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000117	-0.29	-0.21	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103430872	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	3.9	0.000117	0.17	0.21	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	3.9	0.000117	0.17	0.21	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	3.9	0.000117	0.17	0.21	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	3.9	0.000117	0.17	0.21	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	3.9	0.000117	0.17	0.21	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
LIHC	cis	rs10769945	0.679	rs7102920	MIMAT0004761	hsa-miR-483-5p	3.9	0.000118	0.2	0.21	DNA methylation (variation);	chr11:1896642	chr11:2134181~2134202:-
LIHC	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000118	-0.17	-0.21	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
LIHC	cis	rs11186	0.841	rs56074008	MIMAT0019202	hsa-miR-3129-3p	3.9	0.000118	0.41	0.21	Parkinson's disease;	chr2:189082270	chr2:189133044~189133065:-
LIHC	cis	rs1163656	1	rs1163656	MIMAT0003287	hsa-miR-618	-3.88	0.000123	-0.27	-0.21	Dental caries;	chr12:80943679	chr12:80935796~80935818:-
LIHC	cis	rs1075265	0.73	rs7597188	MIMAT0018110	hsa-miR-3682-3p	-3.88	0.000124	-0.2	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:54014732	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.73	rs7597189	MIMAT0018110	hsa-miR-3682-3p	-3.88	0.000124	-0.2	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:54014733	chr2:53849136~53849156:-
LIHC	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	3.88	0.000126	0.16	0.21	Migraine;	chr10:103242040	chr10:103394301~103394322:-
LIHC	cis	rs1075265	0.68	rs6715488	MIMAT0018110	hsa-miR-3682-3p	-3.88	0.000126	-0.2	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:54004130	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.749	rs6738369	MIMAT0018110	hsa-miR-3682-3p	-3.88	0.000127	-0.21	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53756547	chr2:53849136~53849156:-
LIHC	cis	rs4921799	0.662	rs11203898	MIMAT0015020	hsa-miR-548v	-3.88	0.000128	-0.25	-0.21	Lung cancer;Adenocarcinoma;	chr8:17679823	chr8:17681588~17681609:-
LIHC	cis	rs4921799	0.662	rs11987569	MIMAT0015020	hsa-miR-548v	-3.88	0.000128	-0.25	-0.21	Lung cancer;Adenocarcinoma;	chr8:17680140	chr8:17681588~17681609:-
LIHC	cis	rs1075265	0.62	rs10192626	MIMAT0018110	hsa-miR-3682-3p	-3.87	0.000129	-0.22	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53760885	chr2:53849136~53849156:-
LIHC	cis	rs7072216	0.621	rs3750605	MIMAT0026738	hsa-miR-1287-3p	3.87	0.000129	0.25	0.21	Metabolite levels;	chr10:98415897	chr10:98395232~98395253:-
LIHC	cis	rs7937682	1	rs11213973	MIMAT0004676	hsa-miR-34b-3p	-3.87	0.000131	-0.31	-0.21	Primary sclerosing cholangitis;	chr11:111668179	chr11:111512987~111513008:+
LIHC	cis	rs11186	0.841	rs72904403	MIMAT0019202	hsa-miR-3129-3p	3.86	0.000135	0.41	0.21	Parkinson's disease;	chr2:189061283	chr2:189133044~189133065:-
LIHC	cis	rs11186	0.57	rs72904488	MIMAT0019202	hsa-miR-3129-3p	3.86	0.000135	0.41	0.21	Parkinson's disease;	chr2:189086366	chr2:189133044~189133065:-
LIHC	cis	rs11186	0.63	rs10931393	MIMAT0019202	hsa-miR-3129-3p	3.86	0.000135	0.35	0.21	Parkinson's disease;	chr2:189089234	chr2:189133044~189133065:-
LIHC	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-3.86	0.000136	-0.21	-0.21	Migraine;	chr10:103273985	chr10:103394341~103394361:-
LIHC	cis	rs1075265	0.548	rs2542575	MIMAT0018110	hsa-miR-3682-3p	-3.86	0.000137	-0.2	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53821221	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.568	rs2542577	MIMAT0018110	hsa-miR-3682-3p	-3.86	0.000137	-0.2	-0.21	Chronotype;Morning vs. evening chronotype;	chr2:53822111	chr2:53849136~53849156:-
LIHC	cis	rs7937682	0.855	rs527078	MIMAT0004676	hsa-miR-34b-3p	-3.86	0.000137	-0.3	-0.21	Primary sclerosing cholangitis;	chr11:111608989	chr11:111512987~111513008:+
LIHC	cis	rs73157695	0.816	rs55808323	MIMAT0027531	hsa-miR-6815-3p	3.86	0.000137	0.21	0.21	Myopia;	chr21:45747496	chr21:45478306~45478326:+
LIHC	cis	rs7937682	1	rs11213980	MIMAT0004676	hsa-miR-34b-3p	3.86	0.000138	0.31	0.21	Primary sclerosing cholangitis;	chr11:111691968	chr11:111512987~111513008:+
LIHC	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	3.86	0.000138	0.27	0.21	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
LIHC	cis	rs4921799	0.662	rs10888142	MIMAT0015020	hsa-miR-548v	-3.85	0.00014	-0.25	-0.21	Lung cancer;Adenocarcinoma;	chr8:17679605	chr8:17681588~17681609:-
LIHC	cis	rs13390641	1	rs72831800	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000142	-0.29	-0.2	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103373759	chr2:102432336~102432357:+
LIHC	cis	rs6120849	0.754	rs6088667	MIMAT0004772	hsa-miR-499a-3p	-3.85	0.000143	-0.28	-0.2	Protein C levels;	chr20:34978919	chr20:34990445~34990466:+
LIHC	cis	rs73157695	0.963	rs914243	MIMAT0027531	hsa-miR-6815-3p	3.85	0.000144	0.21	0.2	Myopia;	chr21:45735402	chr21:45478306~45478326:+
LIHC	cis	rs59372292	0.642	rs2277987	MIMAT0021017	hsa-miR-4999-5p	3.84	0.000144	0.26	0.2	Coronary artery disease;	chr19:8487389	chr19:8389340~8389360:-
LIHC	cis	rs1075265	0.749	rs2357693	MIMAT0018110	hsa-miR-3682-3p	-3.84	0.000144	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53735699	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.783	rs805359	MIMAT0018110	hsa-miR-3682-3p	-3.84	0.000146	-0.22	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53935317	chr2:53849136~53849156:-
LIHC	cis	rs12936587	0.595	rs9911672	MIMAT0003301	hsa-miR-33b-5p	-3.84	0.000147	-0.21	-0.2	Hip circumference;Coronary artery disease or large artery stroke;Coronary heart disease;Coronary artery disease;	chr17:17625356	chr17:17813897~17813916:-
LIHC	cis	rs1075265	0.508	rs12621225	MIMAT0018110	hsa-miR-3682-3p	-3.84	0.000147	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53710040	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.547	rs7557799	MIMAT0018110	hsa-miR-3682-3p	3.84	0.000147	0.21	0.2	Chronotype;Morning vs. evening chronotype;	chr2:53674760	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.568	rs3095756	MIMAT0018110	hsa-miR-3682-3p	-3.84	0.000147	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53822332	chr2:53849136~53849156:-
LIHC	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	3.84	0.000149	0.17	0.2	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	3.84	0.000149	0.17	0.2	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	3.84	0.000149	0.17	0.2	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	3.83	0.00015	0.17	0.2	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	3.83	0.00015	0.17	0.2	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
LIHC	cis	rs1075265	0.704	rs9631059	MIMAT0018110	hsa-miR-3682-3p	-3.83	0.000154	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54015160	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.73	rs6711105	MIMAT0018110	hsa-miR-3682-3p	-3.83	0.000154	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54017775	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.704	rs6711217	MIMAT0018110	hsa-miR-3682-3p	-3.83	0.000154	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54017892	chr2:53849136~53849156:-
LIHC	cis	rs1018697	1	rs7896903	MIMAT0005951	hsa-miR-1307-3p	3.83	0.000155	0.16	0.2	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394301~103394322:-
LIHC	cis	rs7894407	0.504	rs7089271	MIMAT0022727	hsa-miR-1307-5p	-3.82	0.000157	-0.21	-0.2	White matter hyperintensity burden;	chr10:103417157	chr10:103394341~103394361:-
LIHC	cis	rs7937682	1	rs10789843	MIMAT0004676	hsa-miR-34b-3p	3.82	0.000157	0.32	0.2	Primary sclerosing cholangitis;	chr11:111705434	chr11:111512987~111513008:+
LIHC	cis	rs7072216	0.881	rs2147895	MIMAT0026738	hsa-miR-1287-3p	3.82	0.000157	0.23	0.2	Metabolite levels;	chr10:98388551	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.587	rs2296435	MIMAT0026738	hsa-miR-1287-3p	-3.82	0.000159	-0.25	-0.2	Metabolite levels;	chr10:98422528	chr10:98395232~98395253:-
LIHC	cis	rs1075265	0.621	rs2542593	MIMAT0018110	hsa-miR-3682-3p	-3.81	0.000164	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53804299	chr2:53849136~53849156:-
LIHC	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	3.81	0.000165	0.24	0.2	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
LIHC	cis	rs7937682	0.961	rs1784784	MIMAT0004676	hsa-miR-34b-3p	-3.81	0.000166	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111612461	chr11:111512987~111513008:+
LIHC	cis	rs4574684	0.523	rs9372572	MIMAT0015015	hsa-miR-3144-3p	3.81	0.000167	0.22	0.2	Systemic lupus erythematosus;	chr6:119934003	chr6:120015226~120015247:+
LIHC	cis	rs7937682	1	rs505372	MIMAT0004676	hsa-miR-34b-3p	-3.8	0.000171	-0.31	-0.2	Primary sclerosing cholangitis;	chr11:111636465	chr11:111512987~111513008:+
LIHC	cis	rs1075265	0.729	rs10201364	MIMAT0018110	hsa-miR-3682-3p	-3.8	0.000172	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53990220	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.87	rs17268179	MIMAT0018110	hsa-miR-3682-3p	-3.8	0.000172	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54036876	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.818	rs12713253	MIMAT0018110	hsa-miR-3682-3p	-3.8	0.000172	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54037323	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.783	rs698858	MIMAT0018110	hsa-miR-3682-3p	-3.8	0.000172	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53943333	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.87	rs6749817	MIMAT0018110	hsa-miR-3682-3p	-3.8	0.000174	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54032396	chr2:53849136~53849156:-
LIHC	cis	rs12712133	0.552	rs10200945	MIMAT0019927	hsa-miR-4772-3p	3.79	0.000175	0.21	0.2	Primary biliary cholangitis;	chr2:102268297	chr2:102432336~102432357:+
LIHC	cis	rs1075265	0.756	rs809280	MIMAT0018110	hsa-miR-3682-3p	-3.79	0.000177	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53921270	chr2:53849136~53849156:-
LIHC	cis	rs12712133	0.514	rs10188022	MIMAT0019927	hsa-miR-4772-3p	3.79	0.000177	0.21	0.2	Primary biliary cholangitis;	chr2:102258406	chr2:102432336~102432357:+
LIHC	cis	rs7072216	0.881	rs6584192	MIMAT0026738	hsa-miR-1287-3p	3.79	0.000177	0.23	0.2	Metabolite levels;	chr10:98392616	chr10:98395232~98395253:-
LIHC	cis	rs1075265	0.87	rs1421617	MIMAT0018110	hsa-miR-3682-3p	-3.79	0.000179	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54032995	chr2:53849136~53849156:-
LIHC	cis	rs3829655	0.504	rs7251234	MIMAT0004602	hsa-miR-125a-3p	-3.79	0.000179	-0.18	-0.2	Cerebrospinal fluid biomarker levels;	chr19:51614767	chr19:51693306~51693327:+
LIHC	cis	rs11186	0.778	rs59777852	MIMAT0019202	hsa-miR-3129-3p	3.79	0.000181	0.39	0.2	Parkinson's disease;	chr2:189089765	chr2:189133044~189133065:-
LIHC	cis	rs17730929	0.79	rs17087058	MIMAT0005923	hsa-miR-1269a	-3.79	0.000181	-0.52	-0.2	Colorectal cancer (SNP x SNP interaction);	chr4:66366711	chr4:66276890~66276911:+
LIHC	cis	rs4921799	0.64	rs10112153	MIMAT0015020	hsa-miR-548v	-3.78	0.000185	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679023	chr8:17681588~17681609:-
LIHC	cis	rs4921799	0.64	rs10109250	MIMAT0015020	hsa-miR-548v	-3.78	0.000185	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679026	chr8:17681588~17681609:-
LIHC	cis	rs12712133	0.552	rs11123915	MIMAT0019927	hsa-miR-4772-3p	3.78	0.000189	0.21	0.2	Primary biliary cholangitis;	chr2:102264363	chr2:102432336~102432357:+
LIHC	cis	rs1075265	0.749	rs10203095	MIMAT0018110	hsa-miR-3682-3p	-3.77	0.000189	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53737150	chr2:53849136~53849156:-
LIHC	cis	rs7072216	0.763	rs3750601	MIMAT0005878	hsa-miR-1287-5p	3.77	0.000189	0.24	0.2	Metabolite levels;	chr10:98414804	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs2147900	MIMAT0005878	hsa-miR-1287-5p	3.77	0.000189	0.24	0.2	Metabolite levels;	chr10:98414964	chr10:98395271~98395292:-
LIHC	cis	rs1075265	0.54	rs2542587	MIMAT0018110	hsa-miR-3682-3p	-3.77	0.000192	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53788839	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.563	rs2692537	MIMAT0018110	hsa-miR-3682-3p	-3.77	0.000192	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53788840	chr2:53849136~53849156:-
LIHC	cis	rs7072216	0.763	rs2274246	MIMAT0005878	hsa-miR-1287-5p	3.77	0.000192	0.24	0.2	Metabolite levels;	chr10:98415303	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs2274245	MIMAT0005878	hsa-miR-1287-5p	3.77	0.000192	0.24	0.2	Metabolite levels;	chr10:98415325	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs2274244	MIMAT0005878	hsa-miR-1287-5p	3.77	0.000192	0.24	0.2	Metabolite levels;	chr10:98415461	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.77	rs7896828	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000192	0.23	0.2	Metabolite levels;	chr10:98410750	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.881	rs11189591	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000194	0.23	0.2	Metabolite levels;	chr10:98395539	chr10:98395232~98395253:-
LIHC	cis	rs1075265	0.87	rs1363062	MIMAT0018110	hsa-miR-3682-3p	-3.77	0.000194	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54054625	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.783	rs6545376	MIMAT0018110	hsa-miR-3682-3p	-3.77	0.000194	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53987685	chr2:53849136~53849156:-
LIHC	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	3.77	0.000194	0.27	0.2	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
LIHC	cis	rs7072216	0.77	rs7897357	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000196	0.23	0.2	Metabolite levels;	chr10:98403840	chr10:98395232~98395253:-
LIHC	cis	rs2124910	0.779	rs7250820	MIMAT0004485	hsa-let-7e-3p	-3.76	0.000198	-0.12	-0.2	Blood protein levels;	chr19:51536605	chr19:51692838~51692859:+
LIHC	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	3.76	0.000199	0.24	0.2	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
LIHC	cis	rs9646944	0.501	rs7586983	MIMAT0019927	hsa-miR-4772-3p	3.76	0.000201	0.22	0.2	Blood protein levels;	chr2:102411606	chr2:102432336~102432357:+
LIHC	cis	rs1075265	0.783	rs805439	MIMAT0018110	hsa-miR-3682-3p	-3.76	0.000202	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53829437	chr2:53849136~53849156:-
LIHC	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	3.76	0.000203	0.25	0.2	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
LIHC	cis	rs1075265	0.73	rs11893270	MIMAT0018110	hsa-miR-3682-3p	-3.76	0.000203	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54019828	chr2:53849136~53849156:-
LIHC	cis	rs9908552	0.586	rs7207377	MIMAT0000077	hsa-miR-22-3p	3.76	0.000203	0.19	0.2	Schizophrenia;	chr17:1337800	chr17:1713914~1713935:-
LIHC	cis	rs7072216	0.763	rs733345	MIMAT0005878	hsa-miR-1287-5p	3.76	0.000204	0.23	0.2	Metabolite levels;	chr10:98404458	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs733346	MIMAT0005878	hsa-miR-1287-5p	3.76	0.000204	0.23	0.2	Metabolite levels;	chr10:98404568	chr10:98395271~98395292:-
LIHC	cis	rs941898	0.625	rs6575763	MIMAT0003163	hsa-miR-539-5p	-3.75	0.000205	-0.14	-0.2	White matter hyperintensity burden;	chr14:100105425	chr14:101047329~101047350:+
LIHC	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	3.75	0.000205	0.16	0.2	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
LIHC	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	3.75	0.000205	0.16	0.2	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
LIHC	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	3.75	0.000206	0.25	0.2	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	3.75	0.000206	0.25	0.2	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	3.75	0.000206	0.25	0.2	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	3.75	0.000206	0.25	0.2	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
LIHC	cis	rs7894407	0.892	rs10883859	MIMAT0005951	hsa-miR-1307-3p	3.75	0.000208	0.16	0.2	White matter hyperintensity burden;	chr10:103368377	chr10:103394301~103394322:-
LIHC	cis	rs1075265	0.87	rs7569214	MIMAT0018110	hsa-miR-3682-3p	-3.75	0.000208	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53989049	chr2:53849136~53849156:-
LIHC	cis	rs9535307	0.929	rs6561560	MIMAT0000068	hsa-miR-15a-5p	-3.75	0.000209	-0.35	-0.2	Obesity-related traits;	chr13:49765371	chr13:50049167~50049188:-
LIHC	cis	rs7829975	0.54	rs2976909	MIMAT0019728	hsa-miR-4660	-3.75	0.00021	-0.28	-0.2	Mood instability;	chr8:8489180	chr8:9048453~9048475:+
LIHC	cis	rs941898	0.846	rs3783334	MIMAT0004814	hsa-miR-654-3p	-3.75	0.00021	-0.11	-0.2	White matter hyperintensity burden;	chr14:100121942	chr14:101040269~101040290:+
LIHC	cis	rs4921799	0.597	rs35034557	MIMAT0015020	hsa-miR-548v	-3.75	0.000211	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679136	chr8:17681588~17681609:-
LIHC	cis	rs4921799	0.686	rs10112397	MIMAT0015020	hsa-miR-548v	-3.75	0.000211	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679195	chr8:17681588~17681609:-
LIHC	cis	rs4921799	0.513	rs10112412	MIMAT0015020	hsa-miR-548v	-3.75	0.000211	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679236	chr8:17681588~17681609:-
LIHC	cis	rs4921799	0.577	rs10112413	MIMAT0015020	hsa-miR-548v	-3.75	0.000211	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679238	chr8:17681588~17681609:-
LIHC	cis	rs7072216	0.727	rs7915108	MIMAT0005878	hsa-miR-1287-5p	3.75	0.000211	0.23	0.2	Metabolite levels;	chr10:98404684	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.727	rs7901577	MIMAT0005878	hsa-miR-1287-5p	3.75	0.000211	0.23	0.2	Metabolite levels;	chr10:98404685	chr10:98395271~98395292:-
LIHC	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	3.75	0.000212	0.16	0.2	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
LIHC	cis	rs7149242	0.796	rs12588718	MIMAT0004954	hsa-miR-543	-3.74	0.000215	-0.18	-0.2	Platelet count;	chr14:100683268	chr14:101032033~101032054:+
LIHC	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	3.74	0.000216	0.24	0.2	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	3.74	0.000216	0.24	0.2	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
LIHC	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-3.74	0.000217	-0.15	-0.2	Migraine;	chr10:103262005	chr10:103394301~103394322:-
LIHC	cis	rs1075265	0.836	rs11687324	MIMAT0018110	hsa-miR-3682-3p	-3.74	0.000217	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54046589	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.836	rs1363063	MIMAT0018110	hsa-miR-3682-3p	-3.74	0.000217	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54047433	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.575	rs2692531	MIMAT0018110	hsa-miR-3682-3p	-3.74	0.000217	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53776640	chr2:53849136~53849156:-
LIHC	cis	rs7147624	0.608	rs4902413	MIMAT0004808	hsa-miR-625-3p	3.74	0.000217	0.28	0.2	Chronic obstructive pulmonary disease-related biomarkers;	chr14:65720373	chr14:65471153~65471174:+
LIHC	cis	rs7147624	0.573	rs10148699	MIMAT0004808	hsa-miR-625-3p	3.74	0.000217	0.28	0.2	Chronic obstructive pulmonary disease-related biomarkers;	chr14:65732944	chr14:65471153~65471174:+
LIHC	cis	rs7147624	1	rs10083363	MIMAT0004808	hsa-miR-625-3p	3.74	0.000217	0.28	0.2	Chronic obstructive pulmonary disease-related biomarkers;	chr14:65734050	chr14:65471153~65471174:+
LIHC	cis	rs4574684	0.61	rs9401191	MIMAT0015015	hsa-miR-3144-3p	-3.74	0.000217	-0.22	-0.2	Systemic lupus erythematosus;	chr6:119943823	chr6:120015226~120015247:+
LIHC	cis	rs13390641	0.901	rs66579259	MIMAT0019927	hsa-miR-4772-3p	-3.74	0.000217	-0.28	-0.2	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103379406	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs67105777	MIMAT0019927	hsa-miR-4772-3p	-3.74	0.000217	-0.28	-0.2	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103385930	chr2:102432336~102432357:+
LIHC	cis	rs13390641	1	rs7583337	MIMAT0019927	hsa-miR-4772-3p	-3.74	0.000217	-0.28	-0.2	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103386921	chr2:102432336~102432357:+
LIHC	cis	rs73108077	0.736	rs73104088	MIMAT0015077	hsa-miR-3193	3.74	0.000218	0.57	0.2	Red blood cell density in sickle cell anemia;	chr20:31311110	chr20:31607186~31607207:+
LIHC	cis	rs558003	1	rs475883	MIMAT0017991	hsa-miR-3613-3p	3.74	0.000219	0.36	0.2	Hip circumference adjusted for BMI;	chr13:50599596	chr13:49996426~49996449:-
LIHC	cis	rs1018697	0.966	rs6584526	MIMAT0005951	hsa-miR-1307-3p	3.74	0.00022	0.16	0.2	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394301~103394322:-
LIHC	cis	rs7072216	0.65	rs10883089	MIMAT0005878	hsa-miR-1287-5p	3.74	0.00022	0.23	0.2	Metabolite levels;	chr10:98403363	chr10:98395271~98395292:-
LIHC	cis	rs1075265	0.836	rs1421622	MIMAT0018110	hsa-miR-3682-3p	3.74	0.00022	0.2	0.2	Chronotype;Morning vs. evening chronotype;	chr2:54062644	chr2:53849136~53849156:-
LIHC	cis	rs7072216	0.587	rs3814141	MIMAT0026738	hsa-miR-1287-3p	3.74	0.00022	0.24	0.2	Metabolite levels;	chr10:98411271	chr10:98395232~98395253:-
LIHC	cis	rs7937682	0.961	rs552387	MIMAT0004676	hsa-miR-34b-3p	-3.73	0.000221	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111619323	chr11:111512987~111513008:+
LIHC	cis	rs7937682	0.824	rs577044	MIMAT0004676	hsa-miR-34b-3p	-3.73	0.000221	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111619696	chr11:111512987~111513008:+
LIHC	cis	rs1075265	0.756	rs805367	MIMAT0018110	hsa-miR-3682-3p	-3.73	0.000222	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53943956	chr2:53849136~53849156:-
LIHC	cis	rs2782931	1	rs718834	MIMAT0030017	hsa-miR-7702	-3.73	0.000224	-0.21	-0.2	Amyotrophic lateral sclerosis;	chr9:112082519	chr9:111271193~111271214:-
LIHC	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	3.73	0.000226	0.15	0.2	Migraine;	chr10:103261506	chr10:103394301~103394322:-
LIHC	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	3.73	0.000227	0.25	0.2	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
LIHC	cis	rs7894407	0.856	rs7093667	MIMAT0005951	hsa-miR-1307-3p	-3.73	0.000228	-0.16	-0.2	White matter hyperintensity burden;	chr10:103320818	chr10:103394301~103394322:-
LIHC	cis	rs75358501	0.551	rs16838710	MIMAT0014995	hsa-miR-3130-5p	3.73	0.000229	0.26	0.2	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783276~206783296:-
LIHC	cis	rs75358501	0.551	rs16838710	MIMAT0014995_1	hsa-miR-3130-5p	3.73	0.000229	0.26	0.2	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783246~206783266:+
LIHC	cis	rs7937682	0.855	rs7109592	MIMAT0004676	hsa-miR-34b-3p	-3.72	0.000229	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111662381	chr11:111512987~111513008:+
LIHC	cis	rs7937682	0.889	rs7926485	MIMAT0004676	hsa-miR-34b-3p	-3.72	0.000229	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111665946	chr11:111512987~111513008:+
LIHC	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	3.72	0.000229	0.25	0.2	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	3.72	0.000229	0.25	0.2	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	3.72	0.000229	0.25	0.2	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	3.72	0.000229	0.25	0.2	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
LIHC	cis	rs1075265	0.744	rs10203576	MIMAT0018110	hsa-miR-3682-3p	-3.72	0.000229	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54060939	chr2:53849136~53849156:-
LIHC	cis	rs2283831	0.524	rs9613210	MIMAT0005875	hsa-miR-548j-5p	-3.72	0.00023	-0.21	-0.2	Anti-saccade response;	chr22:26560529	chr22:26555274~26555295:-
LIHC	cis	rs7072216	0.881	rs2182169	MIMAT0026738	hsa-miR-1287-3p	3.72	0.000232	0.22	0.2	Metabolite levels;	chr10:98388247	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.726	rs4474372	MIMAT0005878	hsa-miR-1287-5p	3.72	0.000233	0.23	0.2	Metabolite levels;	chr10:98404814	chr10:98395271~98395292:-
LIHC	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	3.72	0.000233	0.25	0.2	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
LIHC	cis	rs1075265	0.87	rs7569370	MIMAT0018110	hsa-miR-3682-3p	-3.72	0.000233	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53989212	chr2:53849136~53849156:-
LIHC	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	3.72	0.000234	0.25	0.2	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	3.72	0.000234	0.25	0.2	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	3.72	0.000234	0.25	0.2	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
LIHC	cis	rs9303401	0.659	rs12946852	MIMAT0004494	hsa-miR-21-3p	3.72	0.000235	0.24	0.2	Cognitive test performance;	chr17:58935976	chr17:59841311~59841331:+
LIHC	cis	rs9303401	0.659	rs62083436	MIMAT0004494	hsa-miR-21-3p	3.72	0.000235	0.24	0.2	Cognitive test performance;	chr17:58954381	chr17:59841311~59841331:+
LIHC	cis	rs9303401	0.659	rs16943326	MIMAT0004494	hsa-miR-21-3p	3.72	0.000235	0.24	0.2	Cognitive test performance;	chr17:58973004	chr17:59841311~59841331:+
LIHC	cis	rs13413635	0.602	rs11687543	MIMAT0018962	hsa-miR-4444	-3.72	0.000236	-0.42	-0.2	Heart rate;	chr2:177778593	chr2:177212768~177212785:+
LIHC	cis	rs13413635	0.602	rs11687543	MIMAT0018962_1	hsa-miR-4444	-3.72	0.000236	-0.42	-0.2	Heart rate;	chr2:177778593	chr3:75214518~75214535:+
LIHC	cis	rs13413635	0.602	rs6759712	MIMAT0018962	hsa-miR-4444	-3.72	0.000236	-0.42	-0.2	Heart rate;	chr2:177781449	chr2:177212768~177212785:+
LIHC	cis	rs13413635	0.602	rs6759712	MIMAT0018962_1	hsa-miR-4444	-3.72	0.000236	-0.42	-0.2	Heart rate;	chr2:177781449	chr3:75214518~75214535:+
LIHC	cis	rs7072216	0.922	rs7097824	MIMAT0026738	hsa-miR-1287-3p	3.71	0.00024	0.22	0.2	Metabolite levels;	chr10:98392042	chr10:98395232~98395253:-
LIHC	cis	rs7937682	0.961	rs11828343	MIMAT0004676	hsa-miR-34b-3p	3.71	0.00024	0.3	0.2	Primary sclerosing cholangitis;	chr11:111620598	chr11:111512987~111513008:+
LIHC	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	3.71	0.00024	0.25	0.2	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
LIHC	cis	rs7937682	0.924	rs10891283	MIMAT0004676	hsa-miR-34b-3p	-3.71	0.000244	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111656948	chr11:111512987~111513008:+
LIHC	cis	rs7937682	0.924	rs10891284	MIMAT0004676	hsa-miR-34b-3p	-3.71	0.000244	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111657013	chr11:111512987~111513008:+
LIHC	cis	rs7937682	0.924	rs875257	MIMAT0004676	hsa-miR-34b-3p	-3.71	0.000244	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111659729	chr11:111512987~111513008:+
LIHC	cis	rs7937682	0.924	rs875258	MIMAT0004676	hsa-miR-34b-3p	-3.71	0.000244	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111659883	chr11:111512987~111513008:+
LIHC	cis	rs7937682	0.924	rs10891286	MIMAT0004676	hsa-miR-34b-3p	-3.71	0.000244	-0.3	-0.2	Primary sclerosing cholangitis;	chr11:111661967	chr11:111512987~111513008:+
LIHC	cis	rs7072216	0.881	rs10883084	MIMAT0026738	hsa-miR-1287-3p	3.71	0.000244	0.22	0.2	Metabolite levels;	chr10:98391432	chr10:98395232~98395253:-
LIHC	cis	rs7937682	0.924	rs7924683	MIMAT0004676	hsa-miR-34b-3p	-3.71	0.000244	-0.29	-0.2	Primary sclerosing cholangitis;	chr11:111685072	chr11:111512987~111513008:+
LIHC	cis	rs11657217	1	rs8081537	MIMAT0019868	hsa-miR-4739	-3.71	0.000245	-0.26	-0.2	Diastolic blood pressure response to hydrochlorothiazide in hypertension;	chr17:79734466	chr17:79707216~79707240:-
LIHC	cis	rs4921799	0.662	rs7462063	MIMAT0015020	hsa-miR-548v	-3.71	0.000245	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17678838	chr8:17681588~17681609:-
LIHC	cis	rs1075265	0.554	rs10168293	MIMAT0018110	hsa-miR-3682-3p	-3.7	0.000248	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53973793	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.567	rs66773232	MIMAT0018110	hsa-miR-3682-3p	-3.7	0.000248	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53973970	chr2:53849136~53849156:-
LIHC	cis	rs7374394	1	rs7374394	MIMAT0022295	hsa-miR-5588-5p	3.7	0.000249	0.24	0.2	Cognitive performance;	chr3:185228061	chr3:185253252~185253272:-
LIHC	cis	rs7374394	1	rs2377372	MIMAT0022295	hsa-miR-5588-5p	3.7	0.000249	0.24	0.2	Cognitive performance;	chr3:185229089	chr3:185253252~185253272:-
LIHC	cis	rs7374394	1	rs2301052	MIMAT0022295	hsa-miR-5588-5p	-3.7	0.00025	-0.24	-0.2	Cognitive performance;	chr3:185235874	chr3:185253252~185253272:-
LIHC	cis	rs7937682	0.793	rs4581484	MIMAT0004676	hsa-miR-34b-3p	3.7	0.000251	0.3	0.2	Primary sclerosing cholangitis;	chr11:111545097	chr11:111512987~111513008:+
LIHC	cis	rs7072216	0.881	rs4345897	MIMAT0026738	hsa-miR-1287-3p	3.7	0.000251	0.22	0.2	Metabolite levels;	chr10:98387303	chr10:98395232~98395253:-
LIHC	cis	rs1075265	0.553	rs2692532	MIMAT0018110	hsa-miR-3682-3p	-3.7	0.000252	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53778962	chr2:53849136~53849156:-
LIHC	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	3.69	0.00026	0.25	0.2	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	3.69	0.00026	0.25	0.2	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	3.69	0.00026	0.25	0.2	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	3.69	0.00026	0.25	0.2	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	3.69	0.00026	0.25	0.2	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	3.69	0.00026	0.25	0.2	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
LIHC	cis	rs950881	0.601	rs3771164	MIMAT0019927	hsa-miR-4772-3p	3.69	0.000262	0.21	0.2	Allergy;	chr2:102375326	chr2:102432336~102432357:+
LIHC	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	3.69	0.000262	0.24	0.2	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	3.69	0.000262	0.24	0.2	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
LIHC	cis	rs1075265	0.84	rs10084355	MIMAT0018110	hsa-miR-3682-3p	-3.69	0.000263	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:54021711	chr2:53849136~53849156:-
LIHC	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-3.69	0.000264	-0.21	-0.2	Migraine;	chr10:103375562	chr10:103394341~103394361:-
LIHC	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	3.68	0.000268	0.25	0.2	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
LIHC	cis	rs7937682	0.924	rs7938360	MIMAT0004676	hsa-miR-34b-3p	-3.68	0.000269	-0.29	-0.2	Primary sclerosing cholangitis;	chr11:111669151	chr11:111512987~111513008:+
LIHC	cis	rs1075265	0.73	rs7601692	MIMAT0018110	hsa-miR-3682-3p	-3.68	0.00027	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53705532	chr2:53849136~53849156:-
LIHC	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	3.68	0.000271	0.16	0.2	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
LIHC	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	3.68	0.000271	0.16	0.2	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
LIHC	cis	rs1075265	0.756	rs3821081	MIMAT0018110	hsa-miR-3682-3p	3.68	0.000272	0.2	0.2	Chronotype;Morning vs. evening chronotype;	chr2:53738252	chr2:53849136~53849156:-
LIHC	cis	rs13390641	1	rs35422004	MIMAT0019927	hsa-miR-4772-3p	-3.68	0.000272	-0.27	-0.2	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103376246	chr2:102432336~102432357:+
LIHC	cis	rs1075265	0.749	rs2692518	MIMAT0018110	hsa-miR-3682-3p	-3.68	0.000273	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53804746	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.783	rs718872	MIMAT0018110	hsa-miR-3682-3p	-3.68	0.000273	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53946569	chr2:53849136~53849156:-
LIHC	cis	rs1075265	0.572	rs62139835	MIMAT0018110	hsa-miR-3682-3p	-3.68	0.000275	-0.2	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53682307	chr2:53849136~53849156:-
LIHC	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	3.68	0.000275	0.25	0.2	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
LIHC	cis	rs546131	0.642	rs523246	MIMAT0019776	hsa-miR-1343-3p	3.68	0.000276	0.24	0.2	Lung disease severity in cystic fibrosis;	chr11:34823464	chr11:34941888~34941909:+
LIHC	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	3.67	0.000278	0.24	0.2	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
LIHC	cis	rs7072216	0.922	rs2296438	MIMAT0026738	hsa-miR-1287-3p	3.67	0.000282	0.22	0.2	Metabolite levels;	chr10:98387138	chr10:98395232~98395253:-
LIHC	cis	rs1420098	0.505	rs1921622	MIMAT0019926	hsa-miR-4772-5p	-3.67	0.000282	-0.2	-0.2	Inflammatory bowel disease;	chr2:102349607	chr2:102432300~102432321:+
LIHC	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	3.67	0.000283	0.15	0.2	Migraine;	chr10:103240612	chr10:103394301~103394322:-
LIHC	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	3.67	0.000285	0.24	0.2	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
LIHC	cis	rs1075265	0.597	rs10490471	MIMAT0018110	hsa-miR-3682-3p	-3.67	0.000286	-0.21	-0.2	Chronotype;Morning vs. evening chronotype;	chr2:53769446	chr2:53849136~53849156:-
LIHC	cis	rs10769945	0.679	rs2137322	MIMAT0004761	hsa-miR-483-5p	-3.67	0.000286	-0.19	-0.2	DNA methylation (variation);	chr11:1896124	chr11:2134181~2134202:-
LIHC	cis	rs11186	0.778	rs7425327	MIMAT0019202	hsa-miR-3129-3p	3.67	0.000286	0.35	0.2	Parkinson's disease;	chr2:189103924	chr2:189133044~189133065:-
LIHC	cis	rs574773	0.71	rs6660537	MIMAT0004515	hsa-miR-29b-2-5p	3.66	0.000288	0.27	0.2	Economic and political preferences;	chr1:206830238	chr1:207802492~207802513:-
LIHC	cis	rs9303401	0.659	rs12600349	MIMAT0004494	hsa-miR-21-3p	-3.66	0.000293	-0.24	-0.2	Cognitive test performance;	chr17:58976884	chr17:59841311~59841331:+
LIHC	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-3.66	0.000293	-0.24	-0.2	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
LIHC	cis	rs7072216	0.806	rs9804285	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000294	0.23	0.2	Metabolite levels;	chr10:98409715	chr10:98395271~98395292:-
LIHC	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-3.66	0.000296	-0.21	-0.2	Migraine;	chr10:103389790	chr10:103394341~103394361:-
LIHC	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs7910014	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98412353	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs7910247	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98412495	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs6584204	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98413823	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.763	rs6584205	MIMAT0005878	hsa-miR-1287-5p	3.66	0.000298	0.23	0.2	Metabolite levels;	chr10:98414049	chr10:98395271~98395292:-
LIHC	cis	rs7072216	0.881	rs7082192	MIMAT0026738	hsa-miR-1287-3p	3.66	0.000298	0.22	0.19	Metabolite levels;	chr10:98392087	chr10:98395232~98395253:-
LIHC	cis	rs1075265	0.563	rs2692536	MIMAT0018110	hsa-miR-3682-3p	-3.65	0.000298	-0.2	-0.19	Chronotype;Morning vs. evening chronotype;	chr2:53788266	chr2:53849136~53849156:-
LIHC	cis	rs9303401	0.659	rs72828726	MIMAT0004494	hsa-miR-21-3p	3.65	0.000301	0.24	0.19	Cognitive test performance;	chr17:58873856	chr17:59841311~59841331:+
LIHC	cis	rs1075265	0.729	rs7571086	MIMAT0018110	hsa-miR-3682-3p	-3.65	0.000303	-0.2	-0.19	Chronotype;Morning vs. evening chronotype;	chr2:54007899	chr2:53849136~53849156:-
LIHC	cis	rs73157695	0.963	rs743352	MIMAT0027531	hsa-miR-6815-3p	3.65	0.000304	0.2	0.19	Myopia;	chr21:45866480	chr21:45478306~45478326:+
LIHC	cis	rs1075265	0.62	rs2542584	MIMAT0018110	hsa-miR-3682-3p	-3.65	0.000309	-0.2	-0.19	Chronotype;Morning vs. evening chronotype;	chr2:53782707	chr2:53849136~53849156:-
LIHC	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	3.64	0.00031	0.26	0.19	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	3.64	0.00031	0.26	0.19	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	3.64	0.00031	0.26	0.19	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	3.64	0.00031	0.26	0.19	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	3.64	0.00031	0.26	0.19	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	3.64	0.00031	0.26	0.19	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
LIHC	cis	rs7937682	0.961	rs491937	MIMAT0004676	hsa-miR-34b-3p	-3.64	0.000311	-0.29	-0.19	Primary sclerosing cholangitis;	chr11:111624223	chr11:111512987~111513008:+
LIHC	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-3.64	0.000311	-0.15	-0.19	Migraine;	chr10:103241568	chr10:103394301~103394322:-
LIHC	cis	rs574773	0.71	rs6663563	MIMAT0004515	hsa-miR-29b-2-5p	3.64	0.000312	0.27	0.19	Economic and political preferences;	chr1:206830232	chr1:207802492~207802513:-
LIHC	cis	rs1559040	0.932	rs10208690	MIMAT0018110	hsa-miR-3682-3p	3.64	0.000312	0.32	0.19	Sudden cardiac arrest;	chr2:54066783	chr2:53849136~53849156:-
LIHC	cis	rs7072216	0.77	rs1061115	MIMAT0026738	hsa-miR-1287-3p	3.64	0.000315	0.23	0.19	Metabolite levels;	chr10:98417292	chr10:98395232~98395253:-
LIHC	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	3.64	0.000315	0.26	0.19	Asthma;	chr2:102344364	chr2:102432300~102432321:+
LIHC	cis	rs4921799	0.662	rs17125108	MIMAT0015020	hsa-miR-548v	-3.64	0.000318	-0.24	-0.19	Lung cancer;Adenocarcinoma;	chr8:17680832	chr8:17681588~17681609:-
LIHC	cis	rs13413635	0.567	rs7585543	MIMAT0018962	hsa-miR-4444	-3.64	0.000319	-0.41	-0.19	Heart rate;	chr2:177756033	chr2:177212768~177212785:+
LIHC	cis	rs13413635	0.567	rs7585543	MIMAT0018962_1	hsa-miR-4444	-3.64	0.000319	-0.41	-0.19	Heart rate;	chr2:177756033	chr3:75214518~75214535:+
LIHC	cis	rs9646944	0.501	rs10176820	MIMAT0019927	hsa-miR-4772-3p	3.64	0.000319	0.21	0.19	Blood protein levels;	chr2:102437960	chr2:102432336~102432357:+
LIHC	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	3.64	0.00032	0.21	0.19	Migraine;	chr10:103347713	chr10:103394341~103394361:-
LIHC	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	3.63	0.000322	0.24	0.19	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
LIHC	cis	rs9303401	0.659	rs3809724	MIMAT0004494	hsa-miR-21-3p	3.63	0.000323	0.24	0.19	Cognitive test performance;	chr17:58983877	chr17:59841311~59841331:+
LIHC	cis	rs73108077	0.92	rs73248560	MIMAT0015077	hsa-miR-3193	3.63	0.000323	0.53	0.19	Red blood cell density in sickle cell anemia;	chr20:31436938	chr20:31607186~31607207:+
LIHC	cis	rs9646944	0.501	rs34946515	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000323	0.21	0.19	Blood protein levels;	chr2:102426860	chr2:102432336~102432357:+
LIHC	cis	rs9646944	0.501	rs10166330	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000323	0.21	0.19	Blood protein levels;	chr2:102433930	chr2:102432336~102432357:+
LIHC	cis	rs9646944	0.501	rs2110736	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000323	0.21	0.19	Blood protein levels;	chr2:102434395	chr2:102432336~102432357:+
LIHC	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000325	0.15	0.19	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
LIHC	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000326	0.15	0.19	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
LIHC	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000326	0.15	0.19	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
LIHC	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000326	0.15	0.19	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
LIHC	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	3.63	0.000328	0.25	0.19	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	3.63	0.000328	0.25	0.19	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
LIHC	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	3.63	0.000328	0.25	0.19	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
LIHC	cis	rs9646944	0.531	rs17027029	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000329	0.21	0.19	Blood protein levels;	chr2:102374188	chr2:102432336~102432357:+
LIHC	cis	rs9646944	0.501	rs12712144	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000329	0.21	0.19	Blood protein levels;	chr2:102379140	chr2:102432336~102432357:+
LIHC	cis	rs9646944	0.501	rs3213733	MIMAT0019927	hsa-miR-4772-3p	3.63	0.000329	0.21	0.19	Blood protein levels;	chr2:102381424	chr2:102432336~102432357:+
LIHC	cis	rs7374394	0.935	rs9851199	MIMAT0022295	hsa-miR-5588-5p	3.63	0.000329	0.23	0.19	Cognitive performance;	chr3:185221563	chr3:185253252~185253272:-
LIHC	cis	rs7374394	0.877	rs28484921	MIMAT0022295	hsa-miR-5588-5p	3.63	0.000329	0.23	0.19	Cognitive performance;	chr3:185221954	chr3:185253252~185253272:-
LIHC	cis	rs7374394	1	rs6803443	MIMAT0022295	hsa-miR-5588-5p	3.63	0.000329	0.23	0.19	Cognitive performance;	chr3:185222264	chr3:185253252~185253272:-
LIHC	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-3.63	0.000331	-0.2	-0.19	Migraine;	chr10:103279291	chr10:103394341~103394361:-
LIHC	cis	rs1075265	0.756	rs2542576	MIMAT0018110	hsa-miR-3682-3p	-3.63	0.000332	-0.2	-0.19	Chronotype;Morning vs. evening chronotype;	chr2:53821659	chr2:53849136~53849156:-
LIHC	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-3.63	0.000333	-0.22	-0.19	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
LIHC	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-3.63	0.000333	-0.22	-0.19	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
LIHC	cis	rs10862219	0.642	rs7133484	MIMAT0003287	hsa-miR-618	3.62	0.000334	0.24	0.19	Neuroticism;	chr12:81012511	chr12:80935796~80935818:-
LIHC	cis	rs7072216	0.666	rs11598689	MIMAT0026738	hsa-miR-1287-3p	3.62	0.000334	0.24	0.19	Metabolite levels;	chr10:98396270	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.621	rs11189595	MIMAT0026738	hsa-miR-1287-3p	3.62	0.000335	0.24	0.19	Metabolite levels;	chr10:98407565	chr10:98395232~98395253:-
LIHC	cis	rs7072216	0.763	rs6584200	MIMAT0005878	hsa-miR-1287-5p	3.62	0.000337	0.23	0.19	Metabolite levels;	chr10:98410280	chr10:98395271~98395292:-
LIHC	cis	rs6578985	0.52	rs7924316	MIMAT0006790	hsa-miR-675-3p	-3.62	0.000337	-0.2	-0.19	Femoral neck bone geometry and menarche (age at onset);	chr11:2152217	chr11:1996768~1996787:-
LIHC	cis	rs1075265	0.597	rs11694711	MIMAT0018110	hsa-miR-3682-3p	-3.62	0.000337	-0.19	-0.19	Chronotype;Morning vs. evening chronotype;	chr2:53971924	chr2:53849136~53849156:-
LIHC	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	3.62	0.000339	0.25	0.19	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
LIHC	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-3.62	0.00034	-0.2	-0.19	Migraine;	chr10:103273258	chr10:103394341~103394361:-
LIHC	cis	rs1075265	0.656	rs2542574	MIMAT0018110	hsa-miR-3682-3p	-3.62	0.000341	-0.2	-0.19	Chronotype;Morning vs. evening chronotype;	chr2:53820295	chr2:53849136~53849156:-
LIHC	cis	rs1562975	0.855	rs17583088	MIMAT0003241	hsa-miR-576-5p	3.62	0.000345	0.26	0.19	Height;	chr4:108513300	chr4:109488713~109488734:+
LIHC	cis	rs7072216	0.881	rs1079179	MIMAT0026738	hsa-miR-1287-3p	3.62	0.000345	0.22	0.19	Metabolite levels;	chr10:98389589	chr10:98395232~98395253:-
LIHC	cis	rs13390641	1	rs72831801	MIMAT0019927	hsa-miR-4772-3p	-3.62	0.000346	-0.26	-0.19	Blood pressure (anthropometric measures interaction);Blood pressure;	chr2:103373973	chr2:102432336~102432357:+
LIHC	cis	rs7072216	0.727	rs7913541	MIMAT0005878	hsa-miR-1287-5p	3.61	0.000347	0.23	0.19	Metabolite levels;	chr10:98412722	chr10:98395271~98395292:-
LIHC	trans	rs8028182	0.725	rs8024276	MIMAT0003296	hsa-miR-627-5p	-6.15	2.25e-09	-0.57	-0.32	Sudden cardiac arrest;	chr15:75407182	chr15:42199630~42199651:-
LIHC	trans	rs8028182	0.725	rs74422833	MIMAT0003296	hsa-miR-627-5p	-6.12	2.57e-09	-0.54	-0.32	Sudden cardiac arrest;	chr15:75579180	chr15:42199630~42199651:-
LIHC	trans	rs3013169	0.684	rs11753432	MIMAT0006790	hsa-miR-675-3p	6.07	3.5e-09	0.35	0.31	Schizophrenia;	chr6:64217923	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.648	rs6916780	MIMAT0006790	hsa-miR-675-3p	-6.04	3.97e-09	-0.35	-0.31	Schizophrenia;	chr6:64232288	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.657	rs9344919	MIMAT0006790	hsa-miR-675-3p	6.03	4.37e-09	0.35	0.31	Schizophrenia;	chr6:64248107	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.657	rs7762802	MIMAT0006790	hsa-miR-675-3p	6	4.95e-09	0.35	0.31	Schizophrenia;	chr6:64216368	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.684	rs4710263	MIMAT0006790	hsa-miR-675-3p	5.98	5.75e-09	0.34	0.31	Schizophrenia;	chr6:64215143	chr11:1996768~1996787:-
LIHC	trans	rs61776290	0.843	rs284303	MIMAT0002823	hsa-miR-512-3p	5.94	7.23e-09	0.51	0.31	Alcohol dependence (age at onset);	chr1:10630826	chr19:53666729~53666750:+
LIHC	trans	rs61776290	0.843	rs284303	MIMAT0002823_1	hsa-miR-512-3p	5.94	7.23e-09	0.51	0.31	Alcohol dependence (age at onset);	chr1:10630826	chr19:53669213~53669234:+
LIHC	trans	rs3013169	0.684	rs35393694	MIMAT0006790	hsa-miR-675-3p	5.92	7.76e-09	0.34	0.31	Schizophrenia;	chr6:64189779	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.684	rs9362607	MIMAT0006790	hsa-miR-675-3p	5.9	9e-09	0.34	0.31	Schizophrenia;	chr6:64227208	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.684	rs72876897	MIMAT0006790	hsa-miR-675-3p	5.89	9.39e-09	0.34	0.31	Schizophrenia;	chr6:64203504	chr11:1996768~1996787:-
LIHC	trans	rs1671400	1	rs919586	MIMAT0000510	hsa-miR-320a-3p	5.84	1.21e-08	0.38	0.3	Obesity-related traits;	chr8:13317162	chr8:22244975~22244996:-
LIHC	trans	rs3013169	0.684	rs9362570	MIMAT0006790	hsa-miR-675-3p	5.82	1.39e-08	0.33	0.3	Schizophrenia;	chr6:64204365	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.53	rs9451548	MIMAT0006790	hsa-miR-675-3p	-5.81	1.48e-08	-0.33	-0.3	Schizophrenia;	chr6:64419745	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.684	rs35202570	MIMAT0006790	hsa-miR-675-3p	5.8	1.56e-08	0.34	0.3	Schizophrenia;	chr6:64248273	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.684	rs4235967	MIMAT0006790	hsa-miR-675-3p	5.79	1.59e-08	0.34	0.3	Schizophrenia;	chr6:64175391	chr11:1996768~1996787:-
LIHC	trans	rs6919854	0.654	rs9448849	MIMAT0003389	hsa-miR-542-3p	-5.77	1.78e-08	-0.22	-0.3	Daytime sleep phenotypes;	chr6:79905549	chrX:134541364~134541385:-
LIHC	trans	rs3013169	0.567	rs1338825	MIMAT0006790	hsa-miR-675-3p	5.75	2.02e-08	0.32	0.3	Schizophrenia;	chr6:64422091	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.603	rs9359831	MIMAT0006790	hsa-miR-675-3p	5.71	2.51e-08	0.34	0.3	Schizophrenia;	chr6:64218979	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.603	rs9351194	MIMAT0006790	hsa-miR-675-3p	5.71	2.51e-08	0.34	0.3	Schizophrenia;	chr6:64220779	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.603	rs4235968	MIMAT0006790	hsa-miR-675-3p	5.71	2.51e-08	0.34	0.3	Schizophrenia;	chr6:64221414	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.603	rs4235969	MIMAT0006790	hsa-miR-675-3p	5.71	2.51e-08	0.34	0.3	Schizophrenia;	chr6:64221480	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.552	rs9351198	MIMAT0006790	hsa-miR-675-3p	5.71	2.51e-08	0.34	0.3	Schizophrenia;	chr6:64222990	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.603	rs9351199	MIMAT0006790	hsa-miR-675-3p	5.71	2.51e-08	0.34	0.3	Schizophrenia;	chr6:64223430	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.603	rs9351200	MIMAT0006790	hsa-miR-675-3p	5.71	2.51e-08	0.34	0.3	Schizophrenia;	chr6:64223530	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.577	rs4710475	MIMAT0006790	hsa-miR-675-3p	5.71	2.51e-08	0.34	0.3	Schizophrenia;	chr6:64232833	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.684	rs9353659	MIMAT0006790	hsa-miR-675-3p	5.7	2.54e-08	0.33	0.3	Schizophrenia;	chr6:64247927	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.657	rs11968551	MIMAT0006790	hsa-miR-675-3p	5.7	2.64e-08	0.32	0.3	Schizophrenia;	chr6:64447548	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.603	rs587146	MIMAT0006790	hsa-miR-675-3p	-5.69	2.77e-08	-0.33	-0.3	Schizophrenia;	chr6:64384833	chr11:1996768~1996787:-
LIHC	trans	rs61776290	0.843	rs190775	MIMAT0002823	hsa-miR-512-3p	5.69	2.77e-08	0.48	0.3	Alcohol dependence (age at onset);	chr1:10623626	chr19:53666729~53666750:+
LIHC	trans	rs61776290	0.843	rs190775	MIMAT0002823_1	hsa-miR-512-3p	5.69	2.77e-08	0.48	0.3	Alcohol dependence (age at onset);	chr1:10623626	chr19:53669213~53669234:+
LIHC	trans	rs3013169	0.684	rs4484503	MIMAT0006790	hsa-miR-675-3p	5.68	2.93e-08	0.33	0.3	Schizophrenia;	chr6:64181268	chr11:1996768~1996787:-
LIHC	trans	rs3013169	0.657	rs9362532	MIMAT0006790	hsa-miR-675-3p	5.68	2.93e-08	0.33	0.3	Schizophrenia;	chr6:64181612	chr11:1996768~1996787:-